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To detect novel molecules involved in immune functions, a subtracted cDNA
library between two closely related murine lymphoid cell lines was constructed using the
suppression subtractive hybridization (SSH) technique. Both cells are cytotoxic T
lymphocytes, however the 2C is a CDS"^ cytotoxic T cell line and the 5.9 is an
inflammatory CD4^T cell line (Thl). They can both secrete the cytolysin or perforin and
are significantly resistant to cell-mediated lysis. When these two cell lines were
subjected to prolonged exposure to reagents that deplete cells of ATP (2-deoxyglucose,
sodium azide, and potassium cyanide), the 5.9 cell line became substantially susceptible,
but the 2C and other CD8'^ cell line still stood out as being strikingly resistant to granule-
mediated lysis. A modified differential screening of colonies randomly picked from the
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constructed subtractive cDNA library and RNA blot analysis were used to identify cDNA
clones expressed in 2C and/or 5.9 cytotoxic T cell lines. Thirteen cDNA clones were
isolated, from which seven were expressed in both cell lines, and only two were
expressed in 2C but not in 5.9 cell line. All the isolated cDNA clones were sequenced.
A search of the Gene Bank database with the BLAST X program revealed no extensive
homology of IB and 3F cDNA clones to known genes. Limited homology respectively
to a zinc finger motif and the transcription factor MTF-1 were observed. Also RT-PCR
analysis of cells purified from primary mixed lymphocyte reaction, demonstrated that
both IB and 3F cDNA clones were expressed only in CDS"^ but not in CD4‘^ purified
cells. This approach of employing subtraction coupled with partial cDNA sequence
determination can be useful for a first selection of putative functionally relevant
molecules.
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I.l Cells and tissues of the immune system
I.l.lCells of the immune system
Immature precursor cells differentiate into mature effector cells of the immune
system. The precursor cells themselves are developed from the common progenitor cells
known as pluripotent or common haemopoietic stem cell found in the bone marrow.
These progenitor cells also proliferate and renew themselves and acquire new functional
and phenotypic characteristics to become terminally differentiated such as erythrocyte,
megakaryoc5^e, myeloid, or lymphoid progenitor cells. This process of blood cell
production known as haematopoiesis is controlled by a variety of soluble secreted factors
(cytokines/lymphokines) and hormones. At least eight distinct cells terminally
differentiated arise as a result from a single hematopoietic stem cell,
a. The myeloid progenitor cell:
The polymorphonuclear (PMNs) leukocytes or granulocytes are derived from the
common myeloid progenitor cell. The PMNs have a wide variety (poly) of differently
shaped (morpho) nuclei and have granules in their cytoplasm. The PMNs comprise of
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neutrophil, eosinophil, basophil, and mast cell. In addition, monocytes and
macrophages also known as mononuclear phagocytes are derived from the common
myeloid progenitor cell.
b. The Lymphoid Progenitor Cell
The lymphoid progenitor cell gives rise to lymphocytes. The lymphocytes, along
with monocytes and macrophages are also known as mononuclear leukocytes (MNLs)
even though lymphocytes derive from the lymphoid progenitor cells while the
macrophages and monocytes derive from the myeloid progenitor cells (1). Only the
lymphocytes have the ability to specifically recognize foreign antigen molecules such as
those of microorganisms, a feature not possessed by any other cell. Upon stimulation by
antigen, some lymphocytes are triggered to become effector cells performing the function
to eliminate the immunogen, while others become long-lived memory cells that may
persist for years and allow a more rapid response upon second exposure to the
immunogen.
A third population of lymphocytes, known as Large Granular Lymphocytes,
resembles lymphocytes, however they lack the major lymphocytes surface markers and
have distinct granular cytoplasm. The progenitor of large granular lymphocytes has not
yet been identified. Large granular lymphocytes include natural killer (NK) cells, killer
(K) cells, and lymphokine- activated killer (LAK) cells (2). NK cells kill certain tumor
cells and some virally infected cells, but do not recognize a specific antigen. K cells have
molecules on their surface that act as receptors for the end of an antibody that does not
bind antigen (the Fc region of the molecule). K cells express Fc receptors on their
surface, through which they bind antibodies. Fc receptors allow K cells to focus
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cytotoxic activity toward antibody coated-targets in a process referred to as antibody
dependent cellular cytotoxicity (ADCC). The ADCC can also be utilized by some
cytotoxic T cells as well LAK cells, like NK cells do not specifically recognize an
antigen, but are capable of destroying a wider range of targets than NK cells. LAK cells
may be derived from NK cells or cytotoxic T cells.
c. Dendritic cells
Dendritic cells belong to a group of specialized cells collectively called antigen
presenting cell (APC) also called professional antigen presenting cell, that play a critical
role in initiating immune responses. They may transport antigen within them or on their
surface for presentation to naive T cells and thus, like macrophages, play an important
role in helping T cells to respond to antigen.
d. Megakaryocytes and platelets
Megakaryocytic progenitor cells are derived from haematopoietic stem cells.
They undergo endomitosis (producing of multiple copies of DNA within the cell) and
differentiate into megakaryocytes. Platelets are derived from megakaryocytes by a
process, which appears to involve cytoplasmic fragmentation of the cell.
1.1.2 Tissues of the immune system
Lymphocytes are found circulating in the blood, but their large majority are found
either in discrete cluster or organized in specific tissues. The components of this
lymphoid system are categorized as primary, secondary or tertiary lymphoid tissue.
The development and differentiation of lymphocytes are done in the primary lymphoid
tissues that include the thymus and the bursa equivalent tissues (which are the fetal liver
and, probably, the adult bone marrow, respectively, in humans). They are responsible for
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the production of mature “virgin “ lymphocytes not yet exposed to antigen. Secondary
lymphoid tissues allow the accumulation and presentation of antigen to both virgin and
memory lymphocyte populations. The remainder of the body’s tissues may be
considered tertiary lymphoid tissues, where they normally contain only few lymphocytes,
but, during an inflammatory reaction, may be invaded by unique subsets of memory
lymphocytes. This dissertation will discuss mainly about the white blood cells,
particularly the lymphocytes, because they mediate the antigen-specific adaptive immune
response.
1.2 Lymphocytes
Lymphocytes are white blood cells that mediate the antigen-specific adaptive
immune response. Two functional types of antigen-specific lymphocytes are
distinguished: B lymphocytes develop into plasma cells that secrete antibodies and T
lymphocytes develop into effector cells that kill other cells infected with intracellular
pathogens or that activate other cells of the immune system including macrophages and B
lymphocytes.
1.2.1 B lymphocytes
B cells comprise about 5-15 % of the circulating lymphocytes. A distinguishing
feature of B cells is the expression of antibody molecules (immunoglobulin or Ig) on their
surface, which act as the antigen receptor of the cell. The B cell antigen receptor consists
of more than one group of molecules. In addition to the immunoglobulin molecule, the
BCR comprises a duplex of molecules known as Iga and IgP, which have a single
extracellular domain and a cytoplasmic tail. Each antibody molecule contains a region.
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which recognizes and binds to a particular antigen. Pre-B cells are derived from the
common lymphoid progenitor. They are large and have parts of antibody molecules in
their cytoplasm. They differentiate into immature and then mature B cells, which have
antibody and other molecules on their membranes (CD19, CD20, CD23, CD24, CD35
and CD45). After antigenic stimulation, B cells proliferate and differentiate either into
plasma cells, or small resting cells, which are able to respond to the next time that the
same antigen is encountered (memory cells). Plasma cells are designed to produce vast
quantities of antibody, which is secreted outside the cell.
1.2.2 T lymphocytes
Unlike B cells, T cells do not recognize normal antigen in its intact form, rather
they detect antigen presented on cell surface as peptide fragments derived from the
foreign proteins and bound to specialized cell-surface molecules. These specialized
molecules encoded in a complex of genes were entitled major histocompatibility complex
(MHC) because their potent effects on the immune response to transplanted tissues first
identified them. These peptide-binding proteins are still called MHC molecules. The
recognition of antigen as a small peptide fragment displayed by an MHC molecule at the
cell surface is the most distinctive feature of antigen recognition by T cells. To be
associated with MHC gene products, an antigen must be processed, because only short
peptides may associate with the antigen-binding regions of these molecules.
1.2.3 Antigen Processing and Presentation
Two major pathways of antigen processing and presentation can be distinguished
depending partly on sites of replication of infectious agents. Viruses and some bacteria
replicate in the cytosol, while many important pathogenic bacteria and some eukaryotic
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parasites replicate in the vesicular system that includes endosomes and lysosomes. This
pathway also presents Neoantigens expressed by transformed cells. The function of CDS
T cells is to kill virus-infected cells. Pathogens and their toxin products in the vesicular
compartments of cells are detected by CD4 T cell, a different class of T cells. Microbial
antigens may enter the vesicular compartment in either of two ways. Some bacteria, such
as the mycobacteria that cause tuberculosis and leprosy invade macrophages and flourish
in cellular vesicles. Other bacteria in the extracellular spaces may secrete toxins and
other products that are internalized by endocytosis. Here only B cells have a specialized
means of specific antigen uptake in their surface immunoglobulin receptor. CD4 T cells
that are specialized to activate other cells, fall into two functional classes: Thl CD4 T
cells that activate macrophages to kill their internal bacteria, and Th2 CD4 T cells, which
activate B cells to make antibody. To produce an appropriate response to infectious
agents, T cells must be able to accomplish the delivery of peptide fragments to the cell
surface from the different intracellular compartments by two distinct classes of MHC
molecule. MHC class I molecules deliver peptides generated in the cytosol to the cell
surface, where the peptide: MHC complex is recognized by CDS T cells. MHC class n
molecules deliver peptides originating in the vesicular system to the cell surface, where
they are recognized by CD4 T cell.
a. Generation of Peptides Presented by MCH Class 1 Molecules
In general, peptides associated with MHC class I molecules are processed in the
cytoplasm in a highly important regulated mechanism by a large, ATP-dependent,
proteolytic complex called the proteasome. This controlled mechanism allows only
partial degradation and not complete reduction to constituent amino acids. In the
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cytoplasm, the breakdown products are transferred to the lumen of the endoplasmic
reticulum (ER) by the peptide transporters TAPI and TAP2 (Transporter associated with
Antigen Presentation). Once inside the ER, the peptides are to be modified further by
local proteases, producing peptides of correct size for binding to MHC class I. Recent
study has shown that only peptides 8-10 amino acids long can fit the binding groove of a
class I molecule, this length being restricted by the interaction between the amino and
carboxyl termini of the peptide and the extremities of the groove (3).
b. Assembly and Intracellular Transport of MHC Class I Molecules
The heavy and light chains of the MHC class I molecules are synthesized in the
ER. At physiological temperature, the MHC class I heterodimer is unstable, but become
stabilized when associated with presentable peptide. Other molecules transiently
associated with class I heterodimer and released when peptides are bound are thought to
help class I molecules achieve the correct folding upon synthesis. To be presented on the
cell surface, MHC class I-bound peptide must be released from the ER. Upon release, the
class I-peptide complexes are transported via the golgi apparatus and the trans-golgi
reticulum to the cell surface. Antigen processing of MHC class I can be inhibited by two
agents. Brefeldin A blocks movement proteins from the endoplasmic reticulum to the
golgi apparatus, and the adenovirus E3/19K gene product specifically binds to MHC
class I molecules and retains them in the ER.
c. Generation of Peptides Presented by MHC Class II Molecules
MHC class n gene products are expressed only on cells capable of endocytosis
and present antigens derived from an extracellular source. Endosome and lysosome
fusion after endocytosis and degradation of the antigen begins by initial destruction of the
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pathogens. There are three classes of effector cells that can bind to antigens derived
from different types of pathogens presented by the two different classes of MHC
molecule.
Antigens derived from pathogens multiplying in the cytosol are carried to the cell surface
by MHC class I molecules and presented to CDS cytotoxic T cells that kill vims infected
cells. Antigens derived from pathogens in the intracellular vesicles and those from
ingested extracellular bacteria and toxins are carried to the cell surface by MHC class II
molecules and presented to armed effector CD4 T cells that can differentiate into two
types of effector T cells: the inflammatory CD4 T cells (Thl) that activate infected
macrophages to destroy intracellular pathogens and helper T cells (Th2) that activate B
cells to produce antibody.
I.3.1Mechanism of stimulation and activation of naive T cells
The initial interaction of T cells with antigen-presenting cells (APCs) is mediated
by cell adhesion molecules. Cell adhesion molecules are surface receptor molecules
present on professional antigen presenting cells, which by virtue of their interaction with
receptor molecules present on naive T cells, insure that naive T cells can adhere to APC
to sense the presence of antigens collected by APCs. Antigen presenting cells, and
particularly dendritic cells bind naive T cells efficiently through interactions between
lymphocyte function-associated antigens-1 (LFA-1) and CD2 on the T cell and
intercellular adhesion molecules-1, -2, -3 (ICAM-1, -2, and-3) and LFA-3 on the antigen-
presenting cell (figure 1).
Triggering of effector T cells requires not only stimulation of the antigen-specific
receptors, but also either binding of class II or class I molecule respectively to CD4 or the
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tertiary structure of a protein by the reduction of disulphide bonds, thus making it more
accessible to other degradative enzymes that include the cathepsins B, D and E. Peptide
fragments regardless their degree of degradation can bind to MHC class 11, but required
further processing by endosomal proteases to produce a minimal fragment, which
protected from further degradation by the class II molecule itself.
d. Assembly and Intracellular Transport of MHC Class II Molecules
Structurally, class II and class I molecules are similar, but during the assembly,
class II molecules are associated with a third molecule-the invariant chain. Thus, class II
molecules are assembled in the ER as a trimeric complex (composed of an a and P chain
which present the antigen at the cell surface and the invariant chain). In theory. Class I
and class 11 molecules could bind the same peptides because both molecules are
assembled in the ER. However, it had been shown by in vitro studies that class II
molecules only bind peptide fragments after removal of the invariant chain, which
usually occurs beyond the ER. This suggests that the invariant chain may help to regulate
peptide binding, although presentation of cytosolic or ER-derived peptides may occur.
1.3 SpeciHc cell-mediated cytotoxicity: mechanisms of cytotoxic T cells
T lymphocytes assume multiple roles in the defense of an organism against
harmful infection. They can directly kill infected cells, activate macrophages to destroy
intracellular pathogens or activate B cells to secrete antibody leading to destruction of
extracellular pathogens. Adaptive immune responses are induced by antigen and gives
rise to long-lasting protection against disease. Naive T cells must be activated to
proliferate and differentiate into armed effector cells capable of the removal of the
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CDS co-receptors bind to peptide: MHC complexes. A second co-stimulatory signal is
required for clonal expansion of antigen-specific naive T cells. For CD4 T cells, the co¬
stimulatory signal is delivered by B7, also known as BB1 molecule present on the same
APCs on which the T cell recognizes its specific antigen. On T-cell, the receptor of B7
molecule is the molecule CD28. Once activated, the T cells express an additional
receptor called CTLA-4 that binds B7 with a higher affinity than the CD28. In the
absence of co-stimulation, antigen binding to the T cell receptor fails to activate cell and
also leads to the nonresponsive state called anergy. The co-stimulatory signal is
necessary for the synthesis and secretion of IL-2. The requirements for expression of DL-
2 receptor are less stringent than those for IL-2 synthesis. As an example, only ligation
of T-cell receptor is largely sufficient to induce expression of high-affinity IL-2 receptor
on T cells. As discussed later, IL-2 made by one cell can act on IL-2 receptors expressed
on neighboring antigen-specific cells. Naive CD8 T cells require more co-stimulatory
activity than naive CD4 T cells, because their effectors actions are so destructive. This
requirement can be met in two ways. First, activation on APCs with high intrinsic co¬
stimulatory activity can directly stimulate CD8 T cells to synthesize IL-2 that drives their
own proliferation and differentiation. Second, to respond to some viruses and tissue
grafts, cytotoxic T-cells require the presence of CD4 T cells during the priming of the
naive CD8 T cell.
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Figure 1. Cell-surface molecules of the immunoglobulin superfamily are important in
the interactions of lymphocytes with antigen-presenting cells. In the initial encounter of
T cells with antigen-presenting cell, CD2 binding to LFA-3 on the antigen-presenting cell
synergyzes with LFA-1 binding to ICAMs 1, 2, and 3 on the antigen presenting cell.
IC A M -1 IC A M -3
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In these responses, both naive CDS and CD4 T cells must recognize antigen on the
surface of the same APC. It is thought that the action of the CD4 T cell in this case is
necessary to compensate for co-stimulation by APC. This compensatory effect could
occur in one of two ways. If the CD4 T cell is an armed effector cell, it may activate the
APC to express higher levels of co-stimulatory activity, which would enable the APC to
co-stimulate the CDS T cell. Alternatively, the CD4 T cell may be a naive or memory T
cell secreting IL-2 in response to antigen and low levels of co-stimulatory molecules.
IL-2 receptor being able to be induced by receptor ligation alone, the CDS T cell may
express IL-2 receptors even though it cannot produce the IL-2 it needs to drive its own
proliferation. IL-2 in this case comes instead from an adjacent responding CD4 T cell. It
is also known that addition of IL-2 can eliminate the need for a stimulatory signal for
CDS driven activation.
I.3.2Mechanism of cell mediated cytotoxicity
Cytotoxic lymphocytes that include CD4 CTLs, CDS CTLs, NK cells, and LAK
cells can kill virus-infected cells or tumor cells as already mentioned. Cells can die either
by apoptosis or necrosis. Apoptosis, or programmed cell death, is a process by which
cells activate, in response to external stimuli, a program leading within a few hours in
typical morphologic alterations (membrane bebbling, chromatin condensation, cell
shrinking, nucleus fragmentation). Ultimately, it results in death of the cells with
formation of apoptotic bodies, which are normally cleared from the organism by
professional phagocytes. Apoptosis differs from necrosis, uncontrolled and rapid cell
death, by the fact that membrane integrity is normally preserved until the removal of the
cells by phagocytosis, avoiding the risk for the dying cells to release their intracellular
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content and to elicit inflammatory reactions. Cytotoxic T cells thus kill their target
cells using at least three distinct mechanisms, all of which leading to cell death through
the apoptotic pathway:
a. Secretion of cytotoxic cytokines
Most cytotoxic CDS T cells release interferon-y (INF-y) and tumor necrosis
factor-a (TNF-a), which contribute to host defense in several other ways. INF-y has a
direct inhibiting effect on viral replication and induces increased expression of MHC
class I and peptide transporter molecules in infected cells, thus increasing the chance that
infected cells will be recognized as target cells for cytotoxic attack. INF-y also activates
macrophages, recruiting them to sites of infection, both as effector cells and as antigen-
presenting cells. TNF-a and TNF-P can synergize with INF-y in killing some target cells
through a cytokine-mediated pathway as well as through macrophage activation.
b. Calcium-independent contact-dependent cytotoxicity
In the absence of extracellular calcium, target cell death results from the
interaction of the Fas ligand on the CTL (4) and the Fas receptor, a receptor of the TNF-
receptor family (5), in the target cell membrane.
c. Calcium-dependent contact-dependent cytotoxicity
The calcium-dependent pathway relies on the secretion of cytotoxic granules onto
the surface of the target cell and is, therefore, known as the granule exocytosis pathway.
Perforin and granzymes are the two major molecules involved in the granule-mediated
lysis. Both perforin and granzyme have been purified, cloned and characterized via loss-
of-function models in transgenic animals.
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1.3.3 Perforin and lymphocytes’ granzymes
a. perforin characterization
Perforin, also called pore-forming protein (PFP), or cytolysin, or C9-related
■4-'7
protein is responsible for the Ca -dependent contact-dependent lytic activity of granules.
It has been purified from murine, rat and human CTL, NK cell lines and stimulated
peripheral blood lymphocytes (6, 7, 8, 9, 10). Perforin can be separated from other
proteins after solubilization of granule proteins with high salt buffers by gel filtration
chromatography (11, 12) or by affinity chromatography using an anti-C9 anti-serum.
Perforin is a hydrophilic polypeptide with an apparent relative molecular weight (Mr) of
65-70 Kda under nonreducing condition in sodium dodecylsulfate polyacrylamide gel
electrophoresis (SDS Page). When reduced, perforin results in a shift to 75 Kda,
presumably due to disruption of internal cystein bonds. Perforin is found as a tubular
polymer-polyperforin. Electron microscopy of target cell membranes lysed by purified
perforin revealed the presence of typical tubular, ring-like polyperforin structures with
inner diameter of 6-16 nm and height of 16 nm (13, 14). In the presence of Ca'^^, perforin
undergoes ultrastructural changes involving a transition from its monomeric hydrophilic
state into a polymeric amphiphilic form. The tubules formed by polyperforin contain
approximately 12-18 molecules. Pores formed by perforin strikingly resemble lesions
caused by the late events of complement activation, which comprise a sequence of
polymerization reactions in which the terminal complement components interact to form
the membrane attack complex (MAC), or the C9 component (15). The primary structures
of murine, rat and human (16) perforin, have been independently deduced by cDNA
cloning and sequencing. Alignment of the three predicted amino acid sequences reveals
17
considerable identity (69% of the residues are identical between mouse and human
perforin).
The observations of common antigenic epitopes between the lytically active
proteins of late components of the MAC and those of perforin had suggested that they
were both derived from common ancestral genes (17, 18). Sequence comparison of
amino acid between perforin and complement components reveals no significant overall
sequence homology at the N- and C-termini (19) or with any other proteins in the
databank. Approximately only 280 amino acid residues of the central segment of
perforin were found to be homologous (20%) with a region of the complement proteins
C6, Cl C8a, and C9 (20). This region of complements is believed to contain two
functional important cysteine-rich regions: First, a putative lipid binding domain (LB),
residues 167-211 in perforin, 292-333 in C9 is the most conserved region within the
entire sequence and has been proposed to form two amphipathic a-helices that interact
with the lipid bilayer. Second, the central segment, common to all complement proteins
and perforin contains a cystein-rich domain of the low-density lipoprotein (LDL) receptor
or epidermal growth factor precursor (21).
Despite their structural similarities, perforin and C9 complement interact
differently with target cell membranes. Complement C9 insertion into large
multilamellar vesicles or erythrocyte membranes is absolutely dependent on a receptor
moiety assembled from the complement proteins C5b, C6, C7 and C8 (C5b-8) on the
membrane (22). No receptor molecule has been yet reported for perforin. Perforin pore
formation is organized into three main steps. Perforin binds to the target cell membrane,
inserts into the lipid balayer and then polymerizes (23). Perforin binding to target cell is
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Strictly dependent, in contrast, to insertion that can proceed optimally at 37 °C in
physiological ionic strength buffers. Controversy still exists whether perforin delivery to
target cell by exocytosis is sufficient or even necessary for cell death. Purified perforin in
contrast to whole granule preparations does not mediate DNA damage, suggesting that
additional factors are needed. Since serine esterase inhibitors can inhibit DNA
breakdown, several groups propose an involvement of granzymes in the induction of
apoptosis (24). After DNA fragmentation during granule fractionation of either mouse
CTL or rat natural killer cells, two groups had shown that granzyme A (25) and granzyme
B (26) play a role in target cell DNA breakdown. In both cases, DNA breakdown is seen
only if target cells are pretreated either with detergent or perforin. This result suggests
that perforin is necessary for the uptake of the DNA degradation mediator into the target
cell, but until now, the exact mechanism is remains unknown. Shi et al. (27) proposed
that DNA-damaging molecule could be endocytosed by the target cells, as they attempt to
repair the membrane damage induced by perforin. The DNA degradation mediator can
also enter directly the target cells through the pores created by perforin.
b.Lymphocytes’ granzymes
Granzymes are granule-associated serine hydrolases secreted by CTL and NK
cells of murine, rat and human. Six highly related serine esterases, termed granzymes A-
F, have been purified and characterized using granules extracted from murine- IL-2
dependent CTL clones (28); several have been shown to process proteolytic activity. In
human, only four serine proteinases besides perforin and other undefined proteins were
found in granules extracted from CTL and LAK cells. Two of the human granzymes are
homologous to murine granzymes A and B. Granzyme A has a unique structure among
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the serine proteases. It forms a disulfide-linked homodimer of 60 kDa, however
granzymes B-G consist of a single polypeptide chain with relative molecular weight (Mr)
ranging between 27 and 55 kDa. All granzymes, except granzyme C, are antigenetically
related. They are highly homologous and all contain, at equivalent positions, the three
residues His, Asp, and Ser, which form the catalytic center of serine proteases. Mouse
granzymes B, C, E, and F have close physical link to the T-cell receptor-a (TCR-a)-
chain locus on chromosome 14 (29). In contrast, the mouse granzyme A gene is located
on chromosome 13 (30). Human granzyme B, similarly is located close to the TCR-oc/5-
chain locus on chromosome 14 (31). The gene for human granzyme A is localized on
chromosome 5 (32).
Specific substrates are found only for granzymes A, B, and D. Granzymes A and
D show trypsin-like activity cleaving best after Arg or Lys residues, although the activity
of granzyme D is very low compared to that of granzyme A (33). Granzyme A cleaves
Pro-Phe-Arg-7-amino-4-methyl-coumarin, Pro-Phe-Arg-nitroanilide, and BLT most
efficient. Granzyme B has Aspase activity and efficiently hydrolyzes Boc-Ala-Ala-Asp-
SBzl. Granzyme B also has significant activity towards Boc-AIa-AIa-X-SBzI substrates
where X is Asn or Ser. The pH optimum of granzyme A and B for cleavage of the
various substrates is around 8. Granzyme A is inhibited by PMSF, aprotinin DFP, and
benzamidine. Granzyme B activity is blocked by isocoumarins. Using polymerase chain
reaction (PCR) techniques, granzymes A-G are found to be expressed in long-term CDS
and CD4 T-lymphocytes. Specific species of mRNA for granzymes A and B and lesser
extent for granzyme C were detected in both CDS and CD4 T cells primed in vivo and in
vitro short term culture of activated T cells. In contrast, no transcripts for granzymes D-
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G were detected by PCR in either of these effector cell populations, indicating that
these granzymes do not participate in T-cell-mediated function in vivo.
1.3.4 Apoptotic cell death pathway
The cell death that leads to apoptotic features is under genetic control. In mouse,
a homolog of ced-3 gene that was found to govern developmental cell death in nematode
Caenorhaditis elegans (34-36) was found to be interleukin-Ip (IL-IP) converting enzyme
(ICE), a cysteine protease responsible for the processing of pro-IL-lp to the active
cytokine (37). The finding that ICE overexpression in mammalian cells induced
morphological changes associated with apoptosis (38) has led to discovery of several
other family members of novel cysteine proteases that cleave after aspartic acid residues
and can trigger apoptosis when activated (39-57) for this reason, a new designation of
ICE-like proteases has been termed caspases, for cysteine aspartases (listed in table 1).
Caspases exist in an inactive form in the cytosol of most cells as a single polypeptide
chain that is activated by cleavage at specific Asp residues to form active heterodimeric
protease. The observation that this cleavage can be mediated by caspases (either the
same one or others) has led to the idea that apoptosis occurs as a consequence of a
cascade of caspase activation. Consistent with this, in many cases, caspase function is
required for cell death. As a classical example, in Caenorhabditis elegans, mutations in
the CED-3 caspase can produce a phenotype in which there is no programmed cell death
during development (40). In mammals, caspases are required in many situations for cell
death. Peptide caspase inhibitors can effectively block apoptosis induced in cell lines by
ligation of CD95, such that the cells remain fully viable (37). Based on these
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observations, the caspases not only participate in the biochemical and morphological
features of apoptosis but also determine whether or not the cell lives or die. Caspases
that are activated as a consequence of cell membrane signaling events are classified as
initiating or upstream caspases (caspases-2, -8 and -10). Inhibition of upstream
caspasses prevents pro-apoptotic signal transduction via cytoplasmic receptors including
the activation of acidic sphingomyelinase (47). The effectors, or downstream, caspases
(caspases-3, -6, and -7) are activated later than the upstream caspases. These caspases
are principally responsible for the cleavage of crucial substrates [PAK2 or DNA
fragmentation factor (DFF) p45, also called inhibitor of caspase-activated DNase
(ICAD)] involved in the apoptotic degradation phase. Downstream of caspase activation,
the cleavage of caspase substrates leads to systematic dismantling of cell structures,
which translates into apoptotic morphologic lesions (45). Upstream of caspase
activation, a complex series of steps leads from extracellular death signals to caspase
activation (44). First, extracellular ligands engage cytoplasmic membrane receptors.
These receptors are part of, or activate transcription factors, which translocate into the
nucleus. Second, these transcription factors induce the synthesis of molecules, which
govern pathways leading to caspase activation and subsequent cell death.
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Table 1. Nomenclature for interleukin-Ip-converting enzyme (ICE/Ced-3 like human
cysteine proteases (caspases).
Caspase designation Alternative names Refs
Caspase 1 ICE 51
Caspase 2 ICH-1 52
Caspase 3 Apopain, CPP32, Yama 53-55
Caspase 4 ICE(rel)ll, TX, ICH-2 56-58
Caspase 5 ICE(rel)lII, TY 56, 59
Caspase 6 Mch2 20






Caspase 9 Mch5 27,62




1.3.5 SimpliHed models of the perforin/granzyme and Fas mediated killing
The granules of CTLs and their constituent proteins are synthesized 24-48 hours after
stimulation via the CTL receptor. The newly made perforin, granzymes and other
constituent granule proteins are cytotoxic packaged in secretion granules (30). After the
activated CTL recognizes its target, a tight junction is formed between the effector and
the target cells and the CTL granules vectorially stream towards the site of contact (31)
where the granules are fused with the effector cell plasma membrane and the granule
contents are secreted directly to the target cell membrane. In the presence of calcium,
perforin polymerizes and forms channels in the target cell membrane, through which the
granzymes may pass. After entering the target cell, the granzymes are thought to pass
into the cytoplasm of the cell, where they may act on specific substrates in the apoptotic
cascade.
a. Mechanism of perforin/granzyme mediated killing
• Probable perforin/granzyme mechanism leading to the target
cell death
Granzymes, particularly granzyme B, a serine esterase shows enzymatic specificity
similar to that of some caspases (32). Accordingly, granzyme B is able to cleave and
therefore activate caspase-3 (33) and a number of other caspases. It can also cleave some
of the known caspase substrates (34). Based on these properties, granzyme B can trigger
both caspase-dependent and caspase-independent signs of cell death (35-38). Granzyme
B can, by itself cross the target cell membrane and move in a protected cytoplasmic
compartment from which perforin might induce its release and thus allow its localization
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into the nucleus (39). It is not clear yet how, when, and where granzyme B acts on its
various caspase and noncaspase substrates, leading to cell death.
• Probable Fas pathway leading to target cell death
One of the best understood mechanisms leading to target cell death is the Fas system.
The Fas system employs the Fas receptor, a member of the TNF family of death receptor
and the Fas ligand, a membrane-associated ligand that is synthesized within several hours
after T cell receptor stimulation.
The display of the Fas ligand on T cell surface makes it possible for the Fas ligand to
interact with Fas receptors on the surface of target cells. Engagement of the Fas receptor
results in the aggregation of its intracellular death domains, leading to the recruitment of
Fas-associated death domain (FADD) and procaspase-8 to form a death-inducing
signaling complex (DISC). In the DISC, FADD and Fas interact via their death domain
(40, 41); procaspase-8 then associates with FADD via the death effector domains of these
two molecules (42-44). Procaspase-8, a member of the caspase family of cysteine
proteases, is in turn activated by proteolytic cleavage after specific aspartic acid (Asp)
residues. Activated caspase-8 is thought to activate additional downstream caspases by
cleaving them after specific Asp residues, ultimately leading to the activation of
procaspase-3 (45, 46). Activated caspase-3 cleaves an inhibitor molecule that is tightly
associated with a nuclease known as caspase-associated Dnase (CAD) (47). Upon
cleavage, this inhibitor of CAD (ICAD), also known as DNA fragmentation factor
45(DFF45) releases the nuclease from the CAD-ICAD complex, thereby allowing the
nuclease to initiate DNA fragmentation and cause the ultimate fate of the cell: death.
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Figure 2. A model of the mechanisms involved in peiforin/granzyme and Fas mediated
killing. After effector and target cells are conjugated, granules are (a) exocytosed into the
space between the effector and the target cell. Perforin polymerizes in the presence of
calcium, and may either (b) form pores in the target cell membrane through which (c) the
granzymes pass. It is also thought that after interaction with specific binding sites,
granzymes, specifically granzyme B is endocytosed during the cell membrane repair
process. In this case, the granzymes are believed to be localized in a protected
cytoplasmic compartment, from which (d) they can be released into the cytoplasm by the
action of perforin. After release, granzymes can be transported directly to the nucleus (e)
where they may act on death substrates, or they may act on death substrates within the
cytoplasm (f, g, h). Granzyme B can cleave several procaspases to their active forms,
leading to the activation of down stream caspases that are translocated to the nucleus
where they can act on death substrates. The Fas system employs the Fas receptor on the
target cell and the Fas ligand, synthesized after T cell stimulation. Engagement of the
Fas receptor results in the aggregation of its intracellular death domains, leading to the
recruitment of Fas-associated death domain (FADD) and procaspase-8 to form a death-
inducing signaling complex (DISC). Activated caspase 8 lead to the activation of
downstream caspases that also can act on death substrates in the nucleus leading to target
cell death.
 
b. Resistance of cells to granule-mediated lysis
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Cells resist perforin-mediated lysis by varying their degrees of sensitivity. This is
done by the varieties of the repair processes developed by the cells, through which
perforin pores are either removed from plasma membranes by endocytosis or ion
gradients are restored by pumps (48, 49). Suppression of perforin channels by cellular
ATP depleting reagents such azide and cyanide had shown that treated cells become
increasingly susceptible for lysis, i.e. cells are even lysed at lower perforin
concentrations. Cytotoxic T lymphocytes are known to be highly resistant to granule-
mediated lysis (49, 50), or to lysis by intact CTLs in vitro (51, 52). When treated with
ATP-depleting reagents, the CTLs remain resistant, in contrast to non-cytotoxic T cells
(49). Experiments conducted on CTLs stimulated in vivo and let in culture for a very
short period of time had shown resistance to granule-mediated lysis.
The resistance of CTLs to perforin-mediated lysis, not affected by ATP depletion
suggests that CTLs’ membranes are either resilient to integration of perforin or to the
formation of pores. Studies using the Ca'^^-responsive fluorophore, indo-1 had
demonstrated that no initial channels formation and then removal are observed in the
CTLs when treated with granules (48). Susceptible tumor cells treated with sub-lytic
concentrations of perforin show rise of intracellular free ca"^^ concentration is followed by
repair of membrane and then restoration of low intracellular free ca"^^. CTLs treated with
10 times the lytic dose for representative tumor cells manifest no initial rise of
intracellular free ca'^^, suggesting that perforin lesions are prevented from forming in
CTL membrane. It must be noted that CTLs, like other cells, are sensitive to other
permeabilizing agents, such as complement or mellitin (49, 52).
CHAPTER II
RATIONALE
Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells are the immune
system’s first line of defense against cancerous and virally infected cells. Considerable
evidence has shown that cytotoxic T Lymphocytes are stimulated to release toxic
cytoplasmic granules when they adhere to and recognize surface antigens on target cells
(53, 54). These granules contain, granzymes and a 70- Kda perforin, a pore-forming
protein (55), also called cytolysin (56) that plays a key role in cytolysis mediated by CTL
‘y,
and NK cells (57-61). In the presence of Ca , perforin binds to membranes and
subsequently inserts into the lipid bilayer of the target cells to form oligomeric pores of
15 to 20 nm in diameter, resembling those of complement and some bacterial toxins. As
a consequence, perforin lyses target cells. After a CTL has damaged its target cell, the
same CTL can recycle to lyse new targets without going to self-destruction. In vitro
studies show that cloned CTLs are highly resistant to lysis mediated by primary and
cloned CTLs or isolated cytotoxic CTL granules (62-64). These observations suggest
that CTLs possess a mechanism that protects them from their own lytic system.
Furthermore, long-term, IL-2-driven CTL clones as well as primary CD8-I- cells isolated
from spleen (62-64) have been shown to be resistant to CTL-mediated lysis (65).
Although the resistance of primary CD8-I- T-cells is effective, it is not as pronounced as
28
29
the resistance displayed by the cloned CTL cell lines, suggesting that during long-term
culture, there is some genetic selection for increased resistance to granule-mediated lysis
How CTL acquires its resistance to granule-mediated lysis still remains unclear.
Investigators have advanced two explanations.
First the resistance of cytotoxic T cell lines could be explained by the rapid and efficient
removal of the inserted perforin from CTL membranes, reminiscent of many nucleated
cells, which reduce their susceptibility to complement-mediated lysis (66). The second
possible explanation of the resistance is that the T cell lines might have unusually active
ion pumps that prevent or promptly restore the marked changes in intracellular ion
concentrations, especially of Ca^^ (67), that result from insertion of perforin channels.
These two possible mechanisms of resistance are well known to be cellular ATP-
dependent. Verret et al. (49) demonstrated that exposure of prospective target cells to
reagents (azide, cyanide, 2-deoxyglucose) that deplete cells of ATP, enhanced the
susceptibility of most cells to granule-mediated lysis, with the exception of the CD8'^
CTLs that remain resistant. Based on this result, two modes of resistance to lysis were
distinguished. An ATP dependent resistance (active), and the other being an ATP
independent resistance (passive). The ATP-dependent mechanism may reflect the
clearing of cell membranes of inserted perforin, similar to the mechanism utilized b many
nucleated cells to reduce their susceptibility to lysis by activated complement through
elimination of inserted complement attack complexes (C5b-8), possibly via endocytosis
of affected plasma membrane (66). In addition, other investigators (Verret et al.,) found
that the active resistance mechanism appears to be well developed in the €04^^ T cells
(both cytolytic and noncytolytic). The mechanism responsible for the ATP-independent
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(passive) resistance of CDS"^ CTLs is still unknown. They also have shown that
various tumor cell lines treated with various proteases such as trypsin, chymotrypsin,
papain,or pronase became more sensitive to granule-mediated lysis. However, cytotoxic
T lymphocyte cell lines, when treated in the same conditions still remained resistant.
According to this result, it appears that the membrane component of CTL is either
inaccessible to protease or not proteinaceous in nature. It is also possible that a protective
molecule may be so abundant on CTL surface membrane that, it is not sufficiently
destroyed by the conditions of proteolysis. Liu, c.c.et al. have found that CTL cell lines
that had both de novo protein synthesis and newly synthesized RNA blocked with
cycloheximide, emitine, or actinomycin D were still resistant to granule-mediated lysis;
this implies that newly synthesized proteins are not required for the resistance of
cytotoxic T lymphocytes. Based on these findings it has been hypothesized that a
surface protein, or complex of proteins constitutively expressed on the membrane of
activated or nonaetivated CTLs, may be responsible of the ATP-independent resistance of
cytotoxic T lymphocytes to their own pore forming protein.
The resistant state of a cytotoxic T lymphocyte (CTL) to their own pore forming
protein would be controlled by the transcriptional activity of a set of genes. The
assumption was made that these genes would not be expressed in other types of cells
(tumor and non-cytotoxic cells). Molecules involve in the resistance of CTL to perforin
might be found by looking for molecules specifically expressed in CTLs. In practice, a
search for such molecules now often takes advantage of the power of molecular biology
techniques, more precisely of the cloning and differentially screening of cDNA library,
both techniques eventually optimized by subtractive enrichment.
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The research project of my thesis dissertation focuses on finding molecules of
mRNA transcripts differentially expressed in cytotoxic resistant T cells versus non
resistant T cells, but using 2C and 5.9 cytotoxic T cell lines as model system. Although
both cell lines are cytotoxic T cells and display resistance to granule-mediated lysis, only
one, the 2C remains resistant in the ATP-independent manner.
To isolate and characterize mRNA transcripts differentially expressed, a
subtracted cDNA library was first constructed between these two cell lines using the
suppression subtractive hybridization technique (68). Randomly selected colonies from
the library were differentially screened with the subtracted cDNA used as radiolabeled
probe. The positively selected cDNA clones were confirmed by virtual northern
hybridization. This is done by hybridizing each radiolabeled positively selected cDNA
clones with the forward and reverse subtracted cDNAs blotted side by side on nylon
membrane. Selected clones were sequenced and database search was conducted using
the BLASTX sequence analysis program. Northern blot analysis of the selected clones
revealed the cDNA clones that are truly differentially expressed (expressed on 2C but not
on 5.9 cloned cell lines).
Cloned 2C and 5.9 cell lines were maintained in culture for several years with the
support of high levels of lL-2, and repeated exposure to granules when periodically
stimulated with target cells. These conditions may favor the induction of proteins. To
find out whether the differentially expressed clones are not cDNA-induced by the culture
conditions, their expression was examined by relative quantitative or standard RT-PCR in
purified CDS'^ and CD4'^ T-cells form primary mixed lymphocyte reaction (MLR) using
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gene specific primers. Cloning and functional characterization of each differentially
expressed cDNA clone will be conducted as future experiments.
CHAPTER III
MATERIALS AND METHODS
In order to maintain ribonuclease-free conditions, special precautions were taken
in the handling and preparation of solutions and glassware. All solutions except the Tris
solution (Tris inactivates DEPC) and also all the microcentrifuge tubes were treated with
DEPC (Diethylpyrocarbonate) overnight and then autoclaved before use in RNA and
cDNA cloning. The glassware, particularly the electrophoresis tank used for
electrophoresis of RNA was cleaned with detergent solution, rinsed in water, dried with
ethanol, and then filled with a solution of 3% H2O2. After 10 minutes, at room
temperature, the electrophoresis gel box was rinsed thoroughly with DEPC treated water.
III.l Preparation of solutions
a. 5 M sodium Chloride (NaCl)
292.2 g of NaCl was dissolved in 800 ml of FS dd H2O. The volume was
adjusted to 1 liter with water and dispensed into aliquots and sterilized by autoclaving.
b. IM Tris, pH 8.0
60.57 g of tris-base was dissolved in 400 ml of Fsdd H2O. The solution was allowed to
equilibrate with concentrated HCl to pH 8.0. FSdd H2O was added up to 500 ml and then
autoclaved. The solution was stored at room temperature
33
34
242 g of Tris-Base was dissolved into 800 ml of FS dd H2O followed by the
addition of 57.1 ml of glacial Acetic Acid and 100 ml of 0.5 M EDTA, pH 8.0. The
volume was adjusted to 1 liter by the addition of water and the solution was stored at
room temperature.
d. Ethidium Bromide (EtBr) (10 mg/ml)
0.5 g of ethidium bromide was added to a 50 ml falcon tube containing 50 ml of
FS dd H2O. The solution was stirred on a magnetic stirrer for several hours to ensure that
the dye has dissolved. The falcon tube was wrapped in aluminum foil and stored at room
temperature.
e. DNA Sample Buffer 6X
0.25 % bromophenol blue
0.25 % xylene cyanol
30 % glycerol in water
Store at room temperature
f. 20% SDS
Solid sodium dodecyl sulfate (SDS) was dissolved at 68 °C for 45 minutes to
make 20 % solution then cooled to room temperature before the pH was adjusted to 7.2.
The solution was stored at room temperature.
g. 0.5M EDTA (Ethylenediamine Tetraacetic Acid)
To a bottle containing 73.05 g of EDTA, 300 ml of FSdd H2O2 was added. The
pH was adjusted to 8.0 and then the volume was completed to 500 ml by addition of
FSddH202. The solution was then autoclaved and then stored at room temperature.
h. 5M NaOH (Sodium Hydroxide)
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To a bottle containing 40 g of NaOH, 200 ml of FSdd H2O was added. The
solution was autoclaved and stored at room temperature.
i. RNA Binding Buffer
0.5 M NaCl
10 mM Tris-HCl (pH 7.5)
1.0 MMEDTA
0.5% SDS
j. RNA Elution Buffer
10 mM Tris-HCl (pH 7.5)
1.0 mMEDTA
0.2% SDS
k. Guanidine Isothiocyanate (GIT) buffer:
To prepare 50 ml of GIT buffer, 23.63 g of guanidine isothiocyanate (4M)
(Fisher Scientific) was dissolved in 49.165 ml of FSdd H2O. A volume of 0.835 ml of
sodium acetate, pH 6.0 (50 mM) was then added. The mixture was passed through a 0.45
|xm filter, followed by the addition of 0.835 ml of 2-P-mercaptoethanol. The solution
was stored in the dark at room temperature.
l. Cesium Chloride solution:
The solution was prepared by dissolving 24 g of CsCl in 25 ml of FSdd H2O, A
volume of 210 pi of 3M Sodium Acetate was added and then the solution was passed
through a 0.2 pm filter. The solution was then stored at room temperature.m.2 X Proteinase K Buffer:
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To a 50 ml conical tube containing 10 ml IM of Tris, pH 7.5 (200mM), 2.5 ml
of 0.5M EDTA, pH 8.0 (25mM), 3.75 ml of 4M NaCl (300 mM), 5.0 ml of 20% SDS and
537 |xl of 18 mg/ml Proteinase K (200 p^g/ml) were added. FSdd H2O was then added up
to 50 ml and then the solution was stored at -20 °C.
n. 20X SSC
To a bottle containing 800 ml of FS dd H20 DEPC treated, 175.3 g of NaCl and
88.2 g of Sodium Citrate were dissolved. The pH was adjusted to 7 with few drops of
concentrated NaOH. The volume was completed to 1 liter with H20 and the solution
was autoclaved and then stored at room temperature.
o. lOX MOPS [3-(N-morpholino)-propanesuIfonic acid] running buffer
To a bottle containing 300 ml of FS dd H20, 20.9 g MOPS was added. The pH
was adjusted to 7 with NaOH followed by the addition of 8.6 ml of 3 M Sodium Acetate
and 10 ml of 0.5 M EDTA, pH 8. The volume of the solution was brought to 500 ml by
addition of FS dd H202. The MOPS solution was stored at room temperature in the
dark.
p. 20X SSPE stock solution
To a bottle containing 800 ml of FS dd H202 DEPC treated, 175.3 g of NaCl,
27.6 g of NaH2P04.H20, and 7.4 of EDTA were dissolved. The pH was adjusted to 7.4
with NaOH and the volume completed to 1 liter. The stock solution was then autoclaved
and stored at room temperature.q.50% Denhardt’s solutions
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This solution was prepared by mixing in a flask containing 300 ml of FS dd
H2O, 3g of ficoll 400, 3 g of polyvinyl pyrollidone and 3 g of BSA (Bovin Serum
Albumin) (fraction V). This solution was stored in aliquots at -20 °C.
r. Salmon Sperm DNA (SSDNA)
In a 15 ml conical tube containing 50 mg SSDNA, 5 ml of FS dd H20 was added.
The tube content was boiled at 95 °C for 10 minutes and then cooled at room
temperature. The DNA was sheared by drawing several times through an ISgauge needle
and then the volume completed with FSdd H2O to 10 ml. The solution was stored in
aliquots at -20 °C.
s. Sephadex G-50 column
Sephadex G-50 (medium) was added to distilled sterile water (10 g of dry powder
yields 160 ml of slurry). The swollen resin was washed several times with distilled
sterile water to remove soluble dextran, which can create problems by precipitating
during ethanol precipitation. Finally the resin was equilibrated in water or TE (pH 7.6),
autoclaved, and stored at 4 °C.
t. 20 RNA sample buffer
To a microcentrifuge tube containing 500 |il formamide, 169 |xl of formaldehyde
(37 % stock)), and 100 |il of 10 X MOPS buffer were added. The sample buffer was
stored at 4 °C until needed.
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u. Prehybridization/hybridization solution (30 ml)
To a 50 ml conical tube, 15 ml formamide, 3 ml 50x Denhardt’s solution, 7.5 ml
20x SSPE, 750 |il 20 % SDS, and 100 lig/ml denatured Salmon sperm DNA were
respectively added. For hybridization, 1x10^ cpm/ml heat denatured probe was added.
IIL2. Agarose gel electrophoresis
a. Preparation of standard agarose gel electrophoresis
Agarose gels were prepared by heating powdered agarose in 100 ml of 1 X TAE
buffer to boiling in a microwave for 3 minutes. The liquid was allowed to cool to 60 °C
and 5 pi of EtBr (10 mg/ml) were added. The gel was poured into an electrophoresis gel
tray in which the well-forming comb was installed. After polymerization, the gel was
immersed in 1% TAE buffer contained in the electrophoresis tank before the removal of
the comb. Before loading the gel, 1/5 volume of 6 X loading buffer (6 X loading buffer
was 25 % glycerol and 0.05% Bromophenol blue) was added to the DNA samples. 5-20
pg DNA/lane was loaded into each well and electrophoresed at 200 V for 1-2 hrs. After
electrophoresis, the gels were visualized on a UV-light box and photographed.
b. Preparation of formaldehyde-agarose gel electrophoresis
1% denaturing agarose gels were prepared by heating powdered agarose in 75 ml of
water to boiling in a microwave for 3 minutes. The liquid was allowed to cool to 60 °C
and then 10 ml of 1 Ox MOPS buffer, 17 ml of formaldehyde (37 % stock), and 5 pi EtBr
(10 mg/ml stock) were respectively added. The mixture was then poured into an
electrophoresis gel tray in a fume hood. While the gel is hardening, the RNA samples
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were prepared adding in each corresponding tube, 15 |i,l sample buffer, 5 pi RNA (10-
20 pg total RNA or 0.5-2 pg poly A"^ RNA) and 4 pi of FSdd H2O. Each mixture was
heated at 65 °C for 5 min and then quenched on ice. 4 pi of the loading solution (30%
glycerol, dye) was added and the gel was loaded. The gel was run in a IX MOPS buffer
with recirculation overnight at 23 V. The gel was visualized on UV-light box to check
the integrity of the RNA and then photographed.
III.3. Routine culture and plating of E. coli
a. Preparation of stock solutions of antibiotics
• Kanamycin stock solution (Kan 25 mg/ml)
125 mg of kanamycin was weighted out in a 15 ml conical tube followed by the
addition of 5ml of water. The stock solution was aliquoted and stored at -20 °C. The
final working concentration was 25 pg/ml.
• Tetracycline stock solution (Tet 15 mg/ml)
75 mg of tetracycline was weight out in a 15 ml conical tube and then 5 ml of water was
added. The stock solution was aliquoted and then store at -20 “C. The final working
concentration was 15 pg/ml.
• Chloramphenical stock solution (Cam 34 mg/ml)
170 mg of chloramphenical was dissolved in 5 ml of 100 % ethanol contained in 15
ml conical tube. The stock solution was then aliquoted and stored at -20 °C. The final
working concentration was 34 pg/ml.
• Ampicillin stock solution (Amp 100 mg/ml)
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To prepare a 100 mg/ml amp stock solution, 500 mg of ampicillin was dissolved in
a 15 ml conical tube containing 5 ml of water. The stock solution was aliquoted and
stored at -20 °C. The final working concentration was 100|lg/ml.
b. Preparations of culture media and agar plates Luria Bernati (LB) broth
To a bottle containing 900 ml of water, 10 g bacto-tryptone, 5 g bacto-yeast
extract and 5 g of NaCl were added. The solutes were well dissolved by stirring and the
pH adjusted to 7.0 with 5 N NaOH. The volume was brought up to 1000 ml by adding
water. The solution was autoclaved and then stored at room temperature. For plates, 15
g/1 of agar was added before autoclaving. When cooled to 60 °C, the appropriate
antibiotic was added and plates were poured, and after solidification, they were stored at
4 °C until needed.
c. 2x YT medium
To a bottle containing 900 ml of water, 16 g bacto-tryptone, 10 g bacto-yeast
extract and 5 g NaCl were added. The solutes were well dissolved and the pH adjusted to
7.0. The volume was brought up to 1000 ml, and the medium autoclaved and then stored
at room temperature. For plates, 15 g/1 of agar was added before autoclaving. When
cooled to 60 °C, the appropriate antibiotic was added and plates were poured, and after
solidification, they were stored at 4 °C until needed.
IIL4. Cell cultures
a. Culture of 2C and 5.9 cell lines
The 2C and 5.9 cell lines were grown in K-10 medium (450 ml RPMI, 22.5 ml K
supplement, 5 ml penn/strep, and 10% FCS), containing irradiated A20 cells plus
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recombinant interleukin-2 (IL-2). For the 5.9 cell line, 50 |Xg/ml ovalbumine was
added. After 3 to 4 weeks of culture, 6.0 x 10^ and 4 x 10* cells were harvested
respectively for 2C and 5.9 cell lines.
b. Preparation the mixed lymphocyte reactions (MLR)
Single cell suspensions were prepared in a petri dish by grinding between the frosted
parts of two slides, the freshly removed spleen from the mouse (Balb/C or Black/6)
followed by the addition of 10 ml of KIO medium. Each single cell suspension was then
transferred into a 15 ml conical tube and then centrifuged at 1000 RPM for 5 minutes.
The supernatant was discarded and then the cell pellet was resuspended into 3 ml of Tris-
buffer ammonium chloride (NH4CI 0.15 M; KHCO3 1.0 M; NaEDTA O.OIM)
c. Generation of CDS T cells by one-way MLR
To generate CD8+ cells, 3.4x10^ Black/6 spleen cells were incubated with equal
number, but irradiated Balb/c spleen cells. The flask was incubated in a humidified
atmosphere of 5% CO2 at 37 °C. After 5 days of culture, the cells were harvested and the
CD8+ cells purified by negative selection.
d. Generation of CD4^ cell ovalbumine primed
3.4x106 Balb/c spleen cells were mixed with 200 |ig of ovalbumin and the
mixture was incubated in a humidified atmosphere of 5% C02 at 37°C. The cells were
harvested after 5 days and the €04"^ purified by negative selection.
e. StempSep For Murine Cells
StempSep is a negative selection system in which the unwanted cells are
immunomagnetically labeled and bound to a magnetic column. The desired cells,
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collected in the column flowthrough, have not had antibody bound to their surface
therefore, they are suitable for further functional and phenotypic studies.
e.l. Sample Preparation
• Recommended Media
Phosphate Buffered Saline (PBS) modified with 2-6% Fetal Bovine Serum (FBS).
PBS is a phosphate Buffer Saline without Ca^'^ or Each prepared MLR was
resuspended at 2-8xl0’ cells/ml in PBS plus FBS plus 5% normal rat serum and
incubated for 15 minutes at 4°C in a refrigerator. Each cell suspension is now ready for
antibody labeling.
e.1.1. Immunomagnetic labeling:
To each cell suspension, 10 |il antibody cocktail per ml of cell was added. The
cells were well mixed and incubated at 4°C in a refrigerator for exactly 15 minutes. The
cells were washed with PBS plus FBS prepared medium and 100 |i.l of anti-biotin
tetrameric antibody complexes was added per ml of cells. The cells were well mixed and
again incubated in at 4 °C for 15 minutes. To the labeled cells, 60 pi of magnetic colloid
was added per ml of cells followed by a final incubation at 4 °C for 15 minutes. The cells
at this step were now ready for magnetic separation.
e.l.2. Magnetic cell separation/ Procedure with gravity feed:
• Coiunm Assembly-Gravity Feed:
The column was assembled as the manufacturer recommended. The magnet was
placed in the stand and all the procedure was performed in a sterile environment. The
stempsep column was removed from its sterile package and placed in the magnet without
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touching the luer fitting. Be careful not to touch any surface with the tip of the luer
lock otherwise, the magnet will grab the column. The 3-way stopcock was removed from
its sterile package and aseptically attached to the column. The blunt end needle was
removed from its sterile package, keeping the cover on the end of the needle until the
column washing step of the column preparation. Aseptically, the hub was attached to the
luer fitting on the stopcock, directly below the column, and all the connections were
checked.
• Column Preparation (0.3” column)
The plug was removed from the top of the column and the 3-way stopcock was
set to allow flow from the side connection into the column. A sterile syringe (included in
the kit) was filled with PBS (without FBS), the air bubbled were removed and then the
syringe was attached to the side connection of the 3-way stopcock. Slowly, the plunger
of the syringe was depressed to delivered PBS up the column until the level of PBS is
above the stainless steel matrix of column. Placing a waste container below the blunt end
needle washed the column, and the cover removed from the needle, the recommended
medium (PBS plus FBS) was added to the top of the column. The 3-way stopcock was
turned so the flow was from the column down through the needle. The recommended
medium was added until three column volumes were collected. The column was kept




The immunomagnetically labeled sample was loaded on the top of the column.
The stopcock was turned to start flow of media down through the needle into the
collection tube. The sample was allowed to run into the matrix. The recommended
medium was added to the top of the column until three column volumes plus the volume
of the start sample were collected. This collected flowthrough fraction was the enriched
cell fraction for the cell enrichment cocktails or the purged cell fraction for the purging
cocktails. The remaining fluid was drained from the column into a waste container and
the used column; syringe, stopcock, etc were disconnected and discarded into appropriate
waste container. The enriched cell fraction was washed three times with K-10 medium
and was now ready for FACS analysis.
d. FACS analysis of the purified CD8^ and CD4^ T cell populations
5 X 10^ cells of each purified population (CDS or CD4) were resuspended in 500
)il of K 10 medium and first, Fc block was added to a final concentration of up to l|ig/10^
cells. Each mixture was incubated on ice for 10 minutes and then washed two times with
K 10 medium. The cell pellet was resuspended again in 500 |xl of KIO medium, followed
by the addition of a mixture of R-PE anti mouse CDSa for the CDS purified cells and
FITC anti mouse CD4 for the CD4 purified cells. Each mixture was made so that R-PE
anti mouse CDSa or FITC anti mouse CD4 had a final concentration of 1 p-g/lO*^ cells.
The mixtures were incubated on ice for 30 minutes, washed 1 time with IX PBS and then
resuspended in 500 |J,1 of IX PBS. The mixture was washed two times with ice-cold
PBS buffer, and then resuspended in 1 ml of IX PBS. CDS"^ and/orCD4^ cells were
sorted from the resuspended cells by flow cytometry.
IIL5. RNA preparations
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a. Total RNA extraction from cultured cells and mouse tissues
Total RNA extraction from mouse tissues and cultured cells was carried out by
two different methods. For preparation of large amount of total RNA from cultured cell
lines, the Guanidinium-Cesium Chloride (69) method was used. Total RNA extraction
from primary cultured cells and mouse tissues was performed using the Single-Step
Guanidinium Acid-Phenol Method (70).
b. Large scale RNA preparation by Guanidinium-Cesium Chloride Method
The cultured cells were pelleted at 1000 RPM for 5 minutes in the Beckman
centrifuge. The supernatant was poured off and the cell pellet washed two times with the
K-10 medium. The cells were resuspended in 18 ml of GIT buffer and vortexed
vigorously. On the top of two SW41 centrifuge tubes containing each 3 ml of CsCl, 9 ml
of the GIT-cell mixture was layered. The RNA was pelleted by centrifugation in the
SW41 rotor for 21 hours at 32 K RPM, 20 °C. The temperature here is very critical
because the CsCl precipitates at lower temperature. After the centrifugation, the GIT
layer and part of the CsCl layer were carefully removed using a Pasteur pipette and
house vacuum. The remaining CsCl layer was carefully decanted without disturbing the
pellet still by using the Pasteur pipette. The RNA pellet appeared translucid. The RNA
pellet was then rinsed with 1 ml of cold 80% EtOH (-20 °C) by swirling gently. The
EtOH was carefully removed with a Pasteur pipette and the RNA pellet was air-dried.
The pellet was then resuspended in 500p.l of IX PK buffer and transferred into a 1.5 ml
of microcentrifuge tube followed by incubation at 50 °C for 60 minutes to completely
solubilize the RNA. An equal volume of buffered phenol was added, mixed by gently
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vortex and then centrifuge for 3 minutes at high speed to separate the phases. The
aqueous phase was transferred to a new tube and re-extracted two times with
phenol/chloroform, followed by a one time extraction with chloroform. To the aqueous
phase transferred to a new tube, 1/10 volume of 3M sodium acetate, pH 6.0 and 2.5
volume of cold 100% EtOH were added. The mixture was inverted several times and left
at -70 °C overnight. The tube was thawed and equilibrated at 40 °C for 10 minutes and
the RNA was then pelleted by centrifugation at 13000 RPM for 45 minutes. The RNA
pellet was washed in 1 ml 70% EtOH for 30 minutes and then in 100 % EtOH for 15
minutes and then air-dried for 10 minutes. The RNA pellet was resuspended in 500 |il of
FSdd treated DEPC water quantitated by UV spectrophotometer reading of an aliquot at
OD260 and then 20 |J,g was run on 1 % denaturing agarose gel.
c. Total RNA extraction from animal tissues
BALB/C and BLACK/6 mice were purchased from and housed at Morehouse
School of Medicine. The mice were killed by cervical dislocation and freshly removed
tissues, were quickly immersed in liquid nitrogen. The frozen tissues were wrapped in a
small piece of aluminum foil and completely immersed in liquid nitrogen until needed.
Each tissue was ground to a fine powder using a pestle and a mortar, keeping it frozen
throughout by sequential addition of liquid nitrogen. To the powder, 800 |il of the
denaturing solution was added drop wise, while homogenizing very well and then passed
through a 21 gauge syringe several times to break chromosomal DNA. The solution was
transferred onto a microcentrifuge tube and then 100 |i.l of 2 M sodium acetate pH 4 was
added. The tube was inverted up and down manually for 10 seconds. A volume of 800
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^,1 of phenol was added and mixed well and mixed well as described above. 200 |il of
chloroform was added and also mixed well by inversion. The tube was incubated on ice
for 15 minutes followed by a centrifugation at 13,000 RPM for 20 minutes using a bentch
to microcentrifuge at room temperature. The supernatant was transferred onto a new tube
followed by the addition of an equal volume of isopropanol (Sigma). The tube was then
incubated at -70 °C for 10 minutes for precipitation and then the RNA precipitate was
concentrated by centrifugation at 13,000 RPM for 30 minutes at room temperature. The
supernatant was decanted and the RNA pellet was resuspended in 300 |il of the
denaturing solution followed by another addition of 300 |il of isopropanol. The mixture
was incubated again at -70 “C for 10 minutes. The RNA was spun down by
centrifugation at 13, 000 RPM for 30 minutes at room temperature. The supernatant was
discarded and the pellet resuspended into 70 % ethanol and left at room temperature for
15 minutes. The tube was centrifuged at 13, 000 RPM for 30 minutes and the supernatant
was discarded. The pellet was washed with 100 % ethanol and then air-dried for 10
minutes. The dried RNA was resuspended in filtered sterile DEPC treated double
distilled water and the concentration determined by OD spectrophotometric UV reading
at 260. 20 p.g of each total RNA was run on 1% formaldehyde denaturing agarose gel.
An OD260/280 ratio from 1.8 to 2.0 was considered as a good RNA preparation to be
utilized in subsequent experiments.
For total RNA extraction from purified cells (CDS and CD4 T cells), the same protocol is
used, however the 800 |il of denaturing solution id added directly on the cell pellet.
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d. Poly RNA purification from total RNA
Oligo (dT)-cellulose was resuspended overnight at room temperature in IX
binding buffer. The resuspended cellulose was then poured up to 1 ml mark into a sterile
dispocolumn. The column was first washed with 30 volumes of the elution buffer and
then equilibrated with an equal volume of IX binding buffer. A solution of 1 mg/ml total
RNA made in 1 mM EDTA (pH 7.0) was first heat-denatured at 70 °C for 5 minutes and
then quickly chilled on ice. To the denatured total RNA, an equal volume of 2X RNA
binding buffer was added at room temperature. The mixture RNA/2X RNA binding
buffer was directly applied onto the column, and the eluate collected immediately in a
sterile tube. As soon the entire mixture entered the column, one column volume of IX
RNA binding buffer was added onto the dispocolumn and the elution continued. The
total collected eluate was again heat-denatured, and reapplied onto the column. This
process was done for a total of two times and thereafter, the column was washed with 2
column volumes of IX RNA binding buffer, collecting 1 ml of fraction at a time. The
OD260 from each collected fraction was read. Initially, the OD260 of the collected
fractions were high as the nonpolyadenylated RNA passes through the column. The later
fractions had very little or no absorbance at 260 nm. PolyA"^ RNA was then eluted from
the column with 3 column volumes of the sterile, RNase-free elution buffer, collecting
200 |il each of the eluted fraction. The OD260 of each collected fraction was read. The
collected fractions of polyA'^ eluted RNA with absorbance at OD260 were pooled and 1/10
of the volume of 3M Sodium Acetate was added followed by the addition of 2.5 volume
of 100% EtOH. The solution was mixed well and then stored at -20 °C overnight for
precipitation. PolyA"^ RNA was recovered by centrifugation at 13,000 RPM for 30
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minutes at room temperature using a bentch top microcentrifuge. The pellet was
washed with 70% and 100 % EtOH and then air-dried as previously described for total
RNA concentration. Each polyA"*^ RNA was redissolved in 30 jil of FS dd DEPC treated
water and spectrophotometrically quantitated. 2 (Xg of each purified mRNA was run on
1% formaldehyde denaturing agarose gel.
IIL6. Genomic DNA preparation from mouse spleen
The freshly removed spleen was ground to a fine powder using a pestle and
mortar, keeping it frozen in liquid nitrogen throughout. The ground tissue was
resuspended in 40 ml of genomic DNA digestion buffer in which proteinase K was added
to a final concentration of 0.1 mg/ml. The mixture was transferred into a 50 ml conical
tube followed by an overnight incubation with shaking at 50 °C. The mixture was split
into two conical tubes and to each tube, an equal volume of phenol and
chloroform/isoamyl alcohol was added. The tubes were mixed very well by vortexing
and then centrifuged for 10 minutes at 4000 RPM. The supernatants were transferred to
new tubes and another phenol/chloroform purification was performed. To new tubes
containing the supernatants, equal volume of chloroform was added followed by
centrifugation at high speed. This was repeated and then the supernatants were
transferred to new tubes, to which y% volume of 7.5 M ammonium acetate and 2 volumes
of 100% EtOH were added. The content of each tube was gently mixed by inversion and
the nucleic acid precipitate was visible at once.
The DNA precipitate was scooped out using the end of a glass rod and rinse in
70 % EtOH then in 100 % EtOH for few seconds. The precipitates were combined in a
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microcentrifuge tube and air-dried. The DNA was allowed to redissolve overnight at
37 °C in 1 ml solution of 1 M Tris-Cl pH 8 and 0.5 M EDTA pH S.The solution of
nucleic acids was RNAse treated and then incubated overnight at 37 °C. After the
overnight incubation, 40 |il of 5 M NaCl and 5 p,l of 20% SDS were added respectively.
For the final purification, 10 |a,l 15.6 mg/ml of proteinase K was added to the
mixture and incubated for 2 hours at 37 °C. Deproteination of the mixture was continued
by addition of equal volume of phenol/chloroform and chloroform alone. The aqueous
phase was transferred to a new tube, and two volumes of 100 % ethanol were added and
the DNA precipitate was again scooped out. The nucleic acid was washed in 70% and
100% ethanol sequentially and then air-dried, before dissolving in 1 ml of FS ddH20 and
quantitated by spectrophotometry at OD 260 nm. A test gel was run using 10 pg of the
prepared DNA.
III.7. PCR-Select cDNA subtraction
III.7.1 Oligonucleotides








5 ’ -CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGCCGAGGT-3 ’
3’- GCCGGCTCCA-5’
PCR primers
PGR primer 1 5’-CTAATACGACTCACTATAGGGC-3’
Nested PCR primer 1 5’-TCGAGCGGCCGCCCGGGCAGGT-3’
Nested PCR primer 2 5’-AGCGTGGTCGCGGCCGAGGT-3’
III.7.2 First-strand cDNA synthesis
For the first-strand cDNA synthesis, each tube of tester and driver containing 2 fig
of poly A+ RNA was spun to dryness using a speed vac concentrator and then the RNA
was resupended into 4pl of FS dd H2O. To each tube, 1 pi of cDNA synthesis primer (10
pM) was added to have a final volume of 5 pi. The mixtures were denatured at 70 °C in
a thermal cycler for 2 minutes, and then quickly cooled on ice for 2 minutes. The tubes
were briefly centrifuged and then, 2 pi of 5X first-strand buffer, Ipl of dNTP mix
(10 mM each), 1 pi of diluted labeled FS dd H20 and 1 pi AMV reverse transcriptase (20
units/pl) were added. The tubes were again briefly centrifuged and immediately
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incubated at 42 °C for 2 hours in an air incubator, after which transferring the tubes on
ice terminated the first-strand cDNA synthesis reactions.
III.7.3 Second strand cDNA synthesis
Generation of the second strand cDNA was carried out by adding 48.4 |i,l of
sterile H2O, 1.6 ill of dNTP mix, and 4.0 |xl of 20 X second-strand enzyme to each tube
of first-strand cDNA. The contents were mixed and then briefly centrifuged. The tubes
were incubated at 16 °C in a waterbath for 2 hours, followed by the addition of 2 p,l of (6
units) T4 DNA polymerase. The tubes were mixed well and quickly spun down and
transferred to a 16 °C waterbath and incubation continued for an additional 30 minutes.
The second-strand cDNA synthesis reaction was terminated by the addition of 4 |il of 20
X EDTA/glycogen mix to each tube. The synthesized double-strand cDNAs were
phenol/chloroform extracted once with method an equal volume of phenol and
chloroform isoamyl alcohol (25:24:1). The aqueous phase was transferred to new tubes,
containing an equal volume of chloroform: isoamyl alcohol (24:1). The tubes were
vortexed and then centrifuged to insure complete removal of the organic solution from
the aqueous phase. The supernatant of each tube was transferred to another new tube
followed by addition of 40 |xl of 4 M ammonium acetate and 300 pi of 100 % ethanol.
The mixture was vortexed and then centrifuged at 14,000 RPM for 45 minutes. The
double-strand cDNA pellets were washed with 70 % then 100% ethanol. The resulting
pellets were then air-dried for 10 minutes. The double-strand cDNA tester and driver
were resuspended into 100 pi of H2O and passed through a G-50 sephadex spin column
to remove the unincorporated nucleotides. Each purified reaction was concentrated in a
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Speed vac concentrator to dryness and then resuspended into 50 |i.l of FS dd H20. For
confirmation of the efficiency of the first-and second-strand cDNA synthesis, a test gel
was run using 10 p,l of each purified cDNA on 1% agarose gel which was dried on a 3
MM sheet and wrapped in commercial wrap (Saran). Autoradiography of the gel was
performed by exposing on film at -70 °C overnight (Kodak XAR-5 film) with
intensifying screen.
111.7.4 Rsa I digestion
A master mix of three restriction enzyme digestion reactions was made by
combining 15 fxl of 10 X Rsa I restriction buffer and 6 |il of Rsa I restriction enzyme. To
each tube containing 43.5 |il of tester and driver cDNA, 6 )xl of the master mix reaction
was added. The tubes were vortexed, briefly centrifuged, and then incubated at 37 °C for
2 hours. To analyze the efficiency of the digest mixture, an aliquot of 5 p,l was run on a
1 % agarose gel and transferred onto a 3MM paper and an exposure on an X-ray film as
described above. The remaining reaction was terminated by addition of 2.5 |xl 20 X
EDTA/glycogen followed by a phenol/chloroform extraction as described above. Each
tester and driver sample pellet was dissolved in 5.5 )il of filtered sterile double distilled
water. At this stage, the preparations of the driver cDNA were completed and stored
at -20 °C until needed.
111.7.5 Adaptor ligation
A 1/5 dilution of the Rsal digested tester cDNA was made by addition of 8 |j.l of
FS dd H20 to a tube containing 2 |il of the digested cDNA.
a. Preparation of adaptor-ligated tester cDNA;
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A 12 |xl of master mix reaction for the ligation reaction was prepared in a
microcentrifuged tube by combining 6 jil of FS dd H2O, 2|il of 5x ligation buffer, and 2
pi of T4 DNA ligase as described in Clontech protocol manual. Typically, the content the
tube was as follow:
In the tube containing the population of tester 1, 2 pi of the tester cDNA, 2 pi of adaptor-
1, and 6 pi of the master mix reaction were respectively added. Similarly in the tube
containing tester 2R, 2 pi of the tester, 2 pi of adaptor 2R, and 6 pi of the master mix
were added. The tubes were briefly centrifuged, and incubated overnight at 16 °C in a
waterbath. The reaction was terminated by the addition 2.5 pi of 20X EDTA/glycogen to
each tube. The tubes were heated at 72 °C for 5 minutes to inactivate the ligase, briefly
centrifuged and processed for ligation efficiency test,
b. Ligation efficiency test
To insure that at least 25 % of the cDNAs have adaptors on both ends, a ligation
efficiency test was performed. The success of the experiment allowed the amplification
of the fragments that spanned the adaptors/junctions of the tester-1 and tester-2R in the
subsequent steps. The ligation efficiency test consisted of a 1/200 dilution of each
adaptors ligated-tester cDNA. All the reagents were combined as described in Clontech
protocol manual kit; an example of the experimental set up is described in the table
below.
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1 2 3 4
Tester-I
(111)
1 1 0 0
Tester-2R
(Ul)
0 0 1 1
G3PDH3’ primer
(Ul)
1 1 1 1
G3PDH5’ primer
(Ul)
0 1 0 1
PCR primer 1
(Ul)
1 0 1 0
Total volume
(ul)
3 3 3 3
Briefly, a master mix for 5 reactions was made by mixing 12.5)il of 10 x PCR buffer
containing 15 mM MgC12, 2.5 |il of dNTP mixed 10 mM, 2.5 |il of high expand fidelity
PCR system, and 92.5 |il of FS dd H2O in a microfuge tube. To each experimental tube
described above, 22 fil of the master mix was added. The tubes were vortexed, briefly
centrifuged, and two drops of mineral oil were added.
The tubes were incubated at 75 °C for 5 minutes in a PCR thermal cycler (Perkin-
Elmer 480 DNA thermal cycler) to extend the adaptors sequences. Immediately, the
cycling was performed as recommended by Clontech protocol manual kit without
modification. A total of 25 cycles were run, and then at the completion, 10 |il of each
PCR product was analyzed on a 2 % agarose gel electrophoresis.
III.7.6 Sequential hybridization reactions




4X hybridization buffer was left to equilibrate at room temperature for at least 20
minutes prior to initiating the hybridization experiment. If precipitate was not observed,
the buffer was used; otherwise, the buffer is prewarmed at 37°C for 10 minutes. For the
experimental 2C and controls provided by the manufacturer, the followings reagents were
combined in two separate labeled hybridization tubes shown in the following table.
Component Hybridization Sample I Hybridization Sample n
Rsa I digested driver cDNA 2 2
Adaptor1-ligated testerl 1 0
Adaptor2R-ligated tester2 0 1
4 X Hybridization Buffer 1 1
Final volume 4 4
One drop of mineral oil was added to each tube, followed by a brief centrifugation. The
samples were heat-denatured at 98 °C for 2 minutes, and an immediate incubation was
done at 68 °C for 9 hours.
b. Second hybridization
To a tube containing lp,l of the driver cDNA, 1|J,1 of 4 x hybridization buffer, and
2|il of FS ddH20 were added. The tube was well mixed and then centrifuged briefly. l|il
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of the mixture was transferred to a new tube followed by the addition of one dropped of
mineral oil. The tube heat-denatured at 98 °C for 3 minutes using a thermal cycler.
Simultaneously, the denatured driver cDNA was mixed with hybridization samples 1 and
2 following the steps described below.
A- Using a micropipettor, set atl5 |xl and fitted with a pipette tip.
B- The pipette tip was allowed to touch the mineral oil/sample interface of the tube
containing hybridization sample 2.
C- The entire sample was carefully drawn halfway into the pipette tip with a small
amount of mineral oil.
D- The pipette tip was removed from the tube, and drawing a small amount of air into the
tip creating a slight air space below the droplet of sample.
E- The steps B through D were repeated with the tube containing the freshly denatured
cDNA driver. The pipette tip contains now both samples separated by a small pocket of
air.
F- The entire mixture was transferred to the tube containing hybridization sample 1, and
pipetting up and down, followed by a brief centrifugation, mixed the content of the tube.
The reaction was then incubated at 68 °C for 10 hours.
To the entire hybridization reaction, 200 |il of the dilution buffer was added and then
mixed by pipetting up and down.
The mixture was immediately heated at 68 °C for 7 minutes and stored at -20 °C.
IIL7.7 PCR amplincation of the subtracted cDNAs
58
Differentially expressed cDNAs were selectively amplified. Prior to the
amplifications, complementary strands of the adaptors were filled in by a brief
preincubation at 75 °C, regenerating the template, the binding site for PCR primer 1.
During the first amplification, only double strand cDNAs with double strand adaptor
sequences on each end are amplified. In the second PCR, nested PCR primers are used to
further reduce the background and enrich for differentially expressed sequences. The
following describes the two PCR amplification experiments (primary and secondary
PCRs).
a. Primary PCR
Three volumes of 1 X time PCR reactions was prepared by mixing in a
microcentrifuge tube 7.5 |il of 10 x PCR buffer, 3)il of 10 }xM PCR primer 1, 1.5 |il of
High Expand Fidelity PCR system, and 55.5 |il of FS dd DEPC H2O. The mixture was
vortexed, briefly centrifuged, and then 24 |a.l was added to a tube containing 1 |il of the
diluted secondary hybridization reaction. The content of each tube was mixed very well
by pipetting up and down followed by the addition of one drop of mineral oil. A
preincubation at 75 °C for 5 minutes was carried out and the cDNA templates were
amplified as per manufacture protocol (Clontech).
b. Secondary PCR
A one third 1/3 dilution of the primary PCR product was made by the addition of
27 jil of FS dd DEPC H2O into a microcentrifuge tube containing 3 |il of the PCR
product. A master mix for reactions was made as described above with the exception that,
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nested PCR primers 1 and 2 R were used. The mixture was vortexed, briefly
centrifuged and then 24 of the master mix was added to a microcentrifuge tube
containing 1 |il of the diluted primary PCR product. The content of the tube was mixed
very well by pipetting up and down followed by the addition of one drop of mineral oil.
The diluted primary PCR product was then amplified as recommended by the Clontech
protocols.
At the completion of the PCR experiment, 10 |il of each PCR product was run on a 2 %
agarose gel electrophoresis.
III.7.8 Subtracted cDNA library construction:
The PCR-select subtracted cDNA library was constructed by directly cloning the
secondary PCR product in a T/A cloning vector (Invitrogen)
a. Recombinant subtracted cDNA construction using T/A cloning
vector:
To a tube containing 2.5 |xl of the secondary subtracted PCR product, 4 [xl of the
pCR-n T/A eloning vector (invitrogen), and 2 |xl of the T4 DNA ligase and 9.5 [Xl of FS
dd DEPC H2O were sequentially added. The content of the tube was mixed very well
and then briefly centrifuged. The ligation reaction was then incubated at 14 °C overnight.
a.l Transformation of DH5a competent cells
• Titration of the transformation reaction
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The frozen DH5a competent cells (GIBCO-BRL) were thawed on ice. Five
borosilicate tubes were labeled and immediately placed on ice. The ligation reaction was
diluted 5 times with FS dd H20. To each labeled microcentrifuge tube, the ligation
reaction was added as described below:






1 |xl of the stock solution
3 |il of the stock solution
2 10,1 of the diluted solution
4 p.1 of the diluted solution
6 pi of the diluted solution
50 pi of the competent cells was added to each tube and immediately placed on ice for 30
minutes. The tubes were transferred at 37 °C in a waterbath for 1 minute and then
returned on ice for an additional 2 minutes. To each tube, 1 ml of 2xYT medium was
added followed by incubation at 37 °C for 1 hour with shaking. Five hundred microliters
of each transformation reaction were plated in duplicates in 2xYT agar plates containing
100 pg/ml of ampicillin. The plates were incubated at 37 °C overnight. Colony growth
was observed in each plate and the dilution that yielded more colonies (>800) on plating
was chosen for future transformation.
a.2 cDNA library construction
To obtain a cDNA library of 8,000 - 10,000 bacterial colonies, four tubes of the
transformation were therefore carried out. After the incubation at 37 °C with shaking, the
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content of the tubes was combined and then plated on a 150 mm petri dish of 2xYT
agar containing 100 pg/ml of ampicillin. Plates were incubated overnight at 37 °C, a
cDNA library of approximately 8,000 bacterial colonies were obtained.
III.8 Screening of the subtracted cDNA library
To screen the subtracted cDNA, colonies randomly picked from the subtracted
cDNA library were arrayed by cDNA dot blots on Immobilon -Ny"^ Transfer Membrane
(MILLIPORE). Each bacterial colony randomly picked was grown overnight in 200 pi
of LB-amp in a 96 well plate. Amplification of each cDNA insert was performed using a
master mix of 100 x reaction yielding for 1 x reaction of 2.0 pi of 10 x PCR buffer, 0.6 pi
of nested primer 1, and nested primer2R, 0.4pl of dNTP mix (10 mM), 0.2 pi of high
fidelity PCR system enzyme, and 15.2 pi of water. Bacterial aliquots of 2 pi per well
were transferred onto a new 96-well plate, to which 18 pi of the PCR mix reaction was
added. The resulting mixture was amplified in a Perkin-Elmer GeneAmp PCR System
9700 as described in Clontech protocol manual kit. A gel electrophoresis of 1 % agarose
was run by loading 12 pi of each PCR product.
To array the cDNAs on the nylon membrane, 5pl of each PCR product were
combined with 5 pi of 0.6 N NaOH in a 96-well plate. The NaOH is used to denature the
DNA for hybridization. 1.5 pi of each mixture was transferred onto the nylon membrane
and this was done in duplicate in each square. Two identical blots were made: one used
for the forward subtracted probe, and the other for the reverse subtracted probe. The two
cDNA blots were neutralized for 4 minutes in 0.5 M Tris-HCl (pH 8.0) and washed with
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FSddH20. The blots were backed for 1 hour in a vacuum oven at 80 °C, and then
stored until needed.
III.8.1 Preparation of the forward-and reverse-subtracted cDNA probes
The forward-subtracted cDNA was made using the same sample stock of
subtracted cDNA used to constmct the subtracted library above. To make the reverse-
subtracted cDNA, subtractive hybridization was performed with the original tester cDNA
as a driver instead and, the driver was used as a tester. The primary PCR products from
the PCR-select cDNA subtraction (forward and reverse) made as previously described,
were amplified and the secondary PCR products were direetly used as probes for
differential screening. Prior to use any subtracted cDNA as a probe, the adaptor
sequences were removed because despite their small sizes, these adaptor sequences may
still have the potential to cause a very high background on an arrayed subtracted library,
a. Removal of the excess adaptor sequences
For the removal of the adaptor sequences, each secondary PCR product was
phenol/chloroform extracted followed by ethanol precipitation as previously described
and centrifugation. Each pellet was resuspended in 28 |i.l of water from which 3 |i.l was
set a side for agarose gel analysis as control undigested. 3 fxl of 10 X buffer and 1.5 (xl of
Rsa I restriction enzyme were added to each tube containing the PCR product. As
additional control for efficiency of Rsal digestion, pUC 18 plasmid diluted to 25 |Xg/ml
was used. The tubes were incubated at 37 °C for 2 hours. To each Rsa I digested PCR
product, l|il of Sma I restriction enzyme was added, followed by incubation at room
temperature for 2 hours. A final digestion was condueted by the addition to each tube of
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10 |i,l of 10 X restriction buffer, l|il of restriction enzyme Eag I and 61 |il of FS dd
water. The tubes were incubated at 37 °C for an additional 2 hours. Each digested PCR
product was phenol/chloroform extracted and the supernatant was passed through a G-50
spin column to remove the digested adaptor sequences. Each purified PCR product was
concentrated using the speed-vac concentrator to dryness and the pellet was resuspended
into 50 |il of FSddH20. The final digested PCR products were analyzed on a 2% agarose
gel; along side with a control non digested PCR product previously saved prior to the
enzyme restriction PCR product experiments.
b. Labeling of cDNA probes by random priming technique
The cDNA probes were radioactively labeled using the high prime DNA labeling
kit (Boehringer Mannheim). During this experiment, the subtracted forward, the
subtracted reverse and the negative hybridization control cDNAs were labeled.
The tube containing each cDNA was heat-denatured at 95 °C for 10 minutes and quickly
chilled on ice for 2 minutes. The tubes were rapidly centrifuged and then 3 |il of dNTPs
(-dCTP) mix, 4 |xl of High Prime reaction mixture, and 5 |xl or 50 |iCi [a-^^P] dCTP,
3000 Ci/mmol, aqueous solution were respectively added. The tubes were incubated at
37 °C for Ihour after which each reaction was terminated by the addition of 1 pi of 0.5 M
EDTA. Filtered sterile DEPC treated water was added to a final volume of 100 pi. Each
reaction was phenol/chloroform extracted and the resulting supernatant was passed
through a G-50 spin column equilibrated with TE (10:1) to remove the unincorporated
dNTPs. 2 pi aliquot of each purified labeled probe was saved for Cerenkov counted (10
CPM/ml) and the remaining stored until needed.
III.8.2 Identification of the differentially expressed cDNA clones
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a. Differential screening of the subtractive sequences from the library
The forward and reverse subtracted labeled cDNA probes were hybridized to the
forward subtracted clones arrayed on nylon membranes.
Each nylon membrane was placed into each hybridization screwcapped glass tube and 5
ml of the hybridization solution was added. The prehybridization reaction was performed
at 42 °C for 5 hours with continuous rotation, after which the solutions were removed and
discarded. Newly prepared hybridization solutions were added to the glass tubes with the
corresponding probe (forward and reverse), which was heat-denatured for 10 minutes at
95 °C then chilled on ice. Each probe was carefully added to the corresponding tube at a
final concentration of 10® CPM/ml of hybridization solution. The hybridization reaction
was carried out at 42 °C with rotation for 18-24 hours. The next day, the hybridization
reaction was carefully discarded in a P waste container, and the filters were washed 3
times at low-stringency with the washing buffer 2xSSC/0.1% SDS at 42 °C for 30
minutes each time. Next, two high-stringency buffer (0.2xSSC/0.1%SDS) washes were
performed at 65 °C for 15 minutes. Each nylon membrane was wrapped in commercial
plastic wrap (Saran) and then exposed to Kodak-XAR film overnight between two
intensifying screens at -70 °C.
b. Confirmation of the differentially screened cDNA clones
To confirm differential screening results, virtual northern blot was done by first
running the forward-and reverse-subtracted cDNAs on agarose/EtBr stained gel
electrophoresis. The gel was denatured by incubation in a denaturing solution (1.5 M
NaCl, 0.5 N NaOH) for 30 minutes. The solution was discarded and the gel was rinsed
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briefly with FS dd DEPC treated water. The gel was immersed in neutralization
solution (1.5 NaCl, IM TrisCl, pH 8) for 30 minutes. The gel was rinsed in FS dd
HaOand blotted overnight onto Immobilon-Ny'^ transfer membrane (MILLIPORE). The
membrane was baked at 80 °C in a vacuum incubator and stored wrapped in aluminum
foil at -20 °C until needed.
Probe preparation was done starting with bacterial clones harboring differentially
hybridizing cDNA sequences, which were grown for plasmids purification.
Differentially expressed cDNA inserts were isolated by PCR using nested PCR primers 1
and 2R (Clontech). The PCR products were run on 1% low melting agarose gel
electrophoresis and each PCR product was purified from the gel by electro-elution. The
purified PCR product was P-labeled as described for random prime labeling technique
and hybridized with the membrane of virtual northern blot.
c. Partial sequencing of the selected cDNA clones
All confirmed differentially expressed cDNA clones by virtual northern
hybridization were sequenced with SP6/T7 primers (INVITROGEN) using Dye or
BigDye Terminator Cycle Sequencing Ready Reaction Kit and ABI 377 automated DNA
sequencer according to the manufacturer recommendations. Approximately 4(X) bp were
compared with databases
d. Pair wise comparison of the selected differentially expressed cDNA
clones
To verify the absence of redundancy in the selected clones, all the positive clones
were pair wise compared using BLAST sequence 2 programs (National Center for
Biotechnology information).
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Total RNA was extracted from various types of cell lines as described before.
20|J,g of each total RNA was run on 1% denaturing agarose gel and transferred onto
Immobilon-Ny"^ transfer membrane. Each radiolabeled probe corresponding to a positive
cDNA clone on the virtual northern blot experiment was hybridized with the RNA
membrane.
e. Southern blot with mouse genomic DNA
Mouse spleen DNA (5|Xg) was digested overnight with restriction enzyme (10
units, Promega). Following size fractionation on a 1% agarose gel at 100 V for 3 hours,
the DNA was transferred to a nylon membrane. cDNA clones differentially expressed
were ^^P-labelled as previously described. Filters were prehybridized at 42 °C for 4 hours
followed by hybridization still at 42 °C overnight. The membranes were washed twice
(15 minutes each time) in 2x SSC and 0.1% SDS at room temperature and twice in 0.1 x
SSC and 0.1 % SDS at 42 °C. Following washing, filters were wrapped in Saran Wrap
and exposed to film overnight.
f. Expression of differentially expressed genes in primary lymphoid
cells
Total RNAs from limited number of cells (250,000 cells) purified from primary
MLR by StempSep were used in RT-PCR. To each tube of purified CDS"^ and CD4‘^
containing 10 |xl of total RNA, 2 pi of random hexamer, 2 pi of dNTPs and 2 pi of FS dd
H20 were added. The mixtures were denatured at 70 °C for 3 minutes, and chilled on ice
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for 2 minutes. The tubes were briefly centrifuged and then, 2|a,I of 10 X RT-PCR
Buffer, and 1 |a.l reverse transcriptase were added. The tubes were again briefly
centrifuged and immediately incubated at 42 °C for 2 hours in an air incubator, after
which transferring the tubes on ice terminated the first-strand cDNA synthesis reactions.
To quantitate and test the efficiency of the first-strand cDNAs synthesized, 18 S
rRNA primers were used as internal control in RT-PCR reactions. These reactions were
conducted by adding into each tube containing 5 p,l of each reverse transcription reaction,
5 )il of 10 X PCR buffer, 1 |il of 18 S primers, 1 |il of dNTPs, 1 |il of Taq DNA
polymerase, and 37 jxl of FS dd H2O. The amplification was performed as recommended
by the Ambion protocol manual. For the expression of differentially expressed cDNAs,
the amplification was done as described above, but using a set of gene specific primers,
1B#1 5’aaccctcccatacccat3’ and 1B#2 5’cgacgcatctatcgg ag3’ for IB cDNA clone and
3F#1 5’cagagctgagtt ctc3’ and 3F#2 5’aggaagagtcta atg3’ for the 3F cDNA clone. The
PCR products were run on 1 % agarose gel electrophoresis and photographed.
III.9 Screening of XTriplEx cDNA library using as probes, the differentially
expressed cDNA positive clones
IIL9.1 Bacterial cultures plating
a. Primary Streak plates
5 |il of each frozen bacterial stock in 25 % glycerol (E. coli strains XLl-Blue and
BM25.8) was streak on LB agar plate with antibiotic, lacking MgS04.
LB/tet plate was used for XLl-Blue and incubated at 37 °C overnight, while
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LB/kan/cam plate was used for MB25.8 and incubated at 31°C overnight.
The two plates were wrapped sealed with parafilm and stored at 4°C until needed,
b. Working Stock plates
An isolated colony from each primary streak was picked and streak on LB/MgS04
with antibiotics. Each plate was incubated and the appropriate temperature
corresponding to each bacterial strain as described above.
IIL9.2 Titering the amplified library
An isolated colony was picked from the XLl-Blue working stock plate and
inoculated into 20 ml of LB/MgS04/maltose broth without antibiotics at 37 °C with
shaking overnight. The bacterial cells were centrifuged at 5000 RPM for 5 minutes and
resuspended in 7.5 ml of 10 mM MgS04. While four 90 mm plates were being warmed
up at 37 °C for 15 minutes, all the dilutions were carried out as recommended by
Clontech protocol. The four tubes were prepared and incubated at 37°C for 15 minutes as
recommended the manufacturer protocol. To each tube, 5 ml of the melting LB/MgS04
soft agar was added. Each tube was poured rapidly onto LB/MgS04 agar plates. The
plates were swirled to promote even agar distribution, and left to harden at room
temperature for 10 minutes followed by incubation (inverted position) at 37 °C for 7
hours, after which the tubes were stored at 4 °C overnight. Well isolated plaques were
observed in all experimental plates and none in control plate (no plaque). Plaque density
correlated with decreased serial phage dilution and the plate with well isolated plaques
was used for titer determination.
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The X TriplEx library was screened using probes from positive clones identified
during northern blot experiment. A library with at least lx 10^ independent clones is
generally representative of mRNA complexity; therefore the initial screening of the true
differentially expressed cDNAs was performed using lx 10^ phage plaques as the starting
point.
b. Generation of 10^ independent plaques
A one third dilution of the titer of the stock library lysate (3.2x 10^ plaque¬
forming units/fil) was made serially by adding to a tube containing 2 pi of the stock
library lysate, 58 pi of 1 X dilution buffer. Next, 20pl of the above dilution was added to
680 pi of 1 X dilution buffer in a new tube. 18 pi of the final dilution was used to obtain
50, 000 plaques/150 mm petri dish (20 plates).
c. Plaque lift to nylon niters
An isolated colony picked from the working stock of XL1-Blue host cells was
inoculated into 15 ml of LB/MgS04/maltose broth in a 50 ml falcon tube and incubated
overnight at 37 °C with shaking. The cells were centrifuged for 5 minutes at 5,000 RPM,
and the pellet resuspended in 7.5 ml of 10 mM MgS04. 18 pi of the above dilution of the
library lysate was combined with 500 pi of the host culture. The bacterial culture and the
phage mixture were incubated at 37 °C for 15 minutes. 9 ml of melting LB/MgS04 soft
agar was added to the mixture and poured onto LB/MgS04 agar plates. The plates were
left at room temperature for 10 minutes to allow the top agar to harden, before incubating
at 37 °C for 9 hours. Plates were stored at 4 °C until needed.
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Membrane filters were first numbered with a ballpoint pen for reference. The
first filter was immersed in the DNA denaturing solution (1.5 M NaCl, 0.5 M NaOH) for
5 minutes, followed by immersion in neutralization solution (1.5 M NaCl, 0.5 M Tris-
HCl, pH 8) for 5 minutes and finally in 2 X SSC for rinsing before blot-drying on 3 MM
paper. The DNA was permanently fixed by baking the immobilon Ny"^ transfer
membrane at 80 °C for 1 hour in a vacuum oven.
d. Hybridization using cDNA probes
Filters were processed prior to hybridization with labeled probes by pre-washing
the filters as follow. The pre-wash solution was poured in a tray and then the baked
filters were immersed in the solution and incubated with gentle rocking for 1 hour at
60 °C. This step reduced backgrounds. In a hybridization chamber container containing
25 ml of pre-hybridization solution, each pre-washed filter was stacked on the top of each
other and completely immersed using forceps. The pre-hybridization was carried out
from 2 hours to overnight at 42 "C with gentle rocking to insure constant wetting of all
membrane filters.
The hybridization reaction was made by mixing in another (different)
hybridization chamber, 10 ml of the hybridization solution and 100 pi of freshly
denatured radiolabeled probe (10^ CPM/ pg). The filters were transferred and stacked as
described above. The hybridization was performed by incubation with gentle rocking
overnight at 42 °C.
e. Washing off the probes from tbe filters
Excess probes were washed off the filters sequentially. First at lower stringency
buffer (2 X SSC, 0.5 % SDS) at room temperature for 30 minutes (two times) then at
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higher stringency buffer (0.2x SSC, O.lx SDS) at 65 °C for 15 minutes (two times).
The filters were wrapped in plastic commercial wrap (Saran) and exposed to film
(KODACK X-RAY FILM) at -70 °C for 48 hours. After developing the film, the filters
were aligned with the autoradiogram placed on fluorescent light box and the
corresponding positive plaques were identified. An agar plug containing several plaques
was removed and placed in 1 ml of sterile lx lambda dilution buffer containing 5%
chloroform. Positive plaques were replated at density 500-1000 plaques on a 150-mm
plate. Single isolated plaques approaching 100 % hybridization were obtained after the
third round of screening (tertiary screening).
f. Converting X phages to plasmid recombinant
The conversion of a XTriplEx phage clone to a pTriplEx plasmid clone required
excision and circularizing a complete plasmid from the recombinant phage. The plasmid
is released by cre-recombinase-mediated recombination at loxp sites. Release occurred
automatically when recombinant phage is transduced into bacterial host expressing ere
recombinase. In this system, E. coli BM25.8 grown at 31 °C provides cre-recombinase
activity. Here the conversion was performed on individual positive plaques picked from
the tertiary screening plates. For the single plaque conversion, an isolated colony of
BM25.8 host cells was picked from the working plate and immediately inoculated to 10
ml of LB broth in a 50-ml falcon tube. The cells were incubated at 31 °C overnight in a
shaking incubator at 150 RPM. Using the overnight cell culture of BM25.8 host, 100 |il
of 1 M MgCl2 was added.
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An agar plug of a well-isolated positive plaque from the tertiary screening was
picked and transferred in ~ 500 |i.l of lx lambda dilution buffer containing 5%
chloroform. To elute the phage from the agar plug, the mixture was left at 4 °C
overnight. In a 15 ml conical tube, 200 |J,1 of the host cell culture and 150 p.1 of the eluted
positive plaque were combined a new tube and immediately incubated at 31 °C for 30
minutes without shaking. After the addition of 400 p.1 of LB broth, incubation continued
at 31 °C with shaking at 225 RPM for 1 hour. 50 p,l of the infected cell suspension was
plated on an LB plates containing ampicillin and incubated at 37 ”C overnight. This gave
well isolated colonies of recombinant bacteria plates. A single colony was picked from
each clone and plasmid was prepared using NucleoBond Plasmid Kit (Clontech).
g. Size determination of the positive plaques
All the prepared plasmids were first run on a 1 % agarose gel and those with larger
size inserts were chosen for restriction enzyme digestion screening using EcoR//Xba/
restriction enzymes. Each tube contained 10 pi of each prepared plasmid; 40 pi of EcoRI
master mix containing 2 pi of enzyme. The tubes were incubated at 37 °C overnight. To
each digested reaction, water was added up to 100 pi followed by ethanol precipitation
and centrifugation. The resulting pellet was resuspended in 10 pi of water and 40 pi of
the Xbai master mixed containing 2 pi of the enzyme, before incubating overnight at 37
°C. Each double digested reaction was ethanol precipitated, and centrifuged in eppendorf
microcentrifuge. The pellet was resuspended in 10 pi DNA 1 X loading buffer before
electrophoresis on 1% agarose gel.
CHAPTER IV
RESULTS
Previous studies have shown that when both the CDS'*^ CTL cell line and the €04"^
CTL cell line were exposed to reagents that deplete cells of ATP, only the CDS"^ CTLs
remained passively resistant to granule-mediated lysis. As an initial investigation toward
identifying gene (s) that are present in CDS"^ CTLs but absent in CD4‘*' CTLs, gene (s)
that may afford the resistance advantage to lysis of CDS"^ CTLs, this researcher sought to
isolate and characterized the molecules that are specifically expressed in CD8+ cell lines.
This chapter of the thesis is divided into four sections. Each of these sections
incorporates at lest one major aspect of my thesis research.
In the first section (section A) is described the principle of the technique used to
construct the subtractive cDNA library.
In the next section, the initial series of experiments reported in section B,
describes the preliminary experiments prior the construction of the subtracted cDNA
library.
In section C are described the experiments used to isolate and characterize the
differentially expressed cDNAs.
In the final section (section D), the expression of the isolated differentially expressed
cDNAs was first determined in primary purified lymphoid cells by RT-PCR, and- then in
attempt to recover full-length cDNA sequences, the differentially expressed
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IV.l Principle of the suppression subtractive hybridization technique
A schematic representation of the SSH method is shown in figure 3. The suppression
subtractive hybridization (SSH) was performed between 2C (tester) and 5.9 (driver)
cytotoxic T cell lines to isolate cDNAs or mRNAs differentially expressed. The 2C cell
line is a CDS cytotoxic T cell that kills virus infected target cells, and the 5.9 is an
inflammatory CD4 T cell that activates macrophages to kill the pathogens they harbor.
Thus the tester cDNAs contain the target genes specifically expressed, and the driver
cDNAs are used for control comparison, since they are deprived of target molecules.
Double-stranded (ds) cDNA was prepared from the tester and driver mRNA. In this
process, tester and driver cDNAs are each digested with the fragment cutter enzyme Rsal,
a restriction enzyme that yields blunt ends cDNA and short fragments. The resulting
tester cDNA fragments are then subdivided into two populations (referred in this thesis
as I and II) and each is ligated with a different double-stranded cDNA adapters referred
as I and 2R at their 5’ends in separate tubes. Two hybridization stages are used during
this subtraction technique. In the first stage, an excess of driver cDNA is added to each
sample of tester cDNA. The samples are then heat-denatured and allowed to anneal,
generating the type a, b, c, and d molecules in each sample (figure 3). During the
hybridization, tester molecules that have a complement in the driver (redundant
molecules) mostly form driver-tester heterohybrids and are removed from the single-
stranded fraction. This process is much more effective for the more abundant redundant
molecules due to the second-order kinetics of hybridization, leading to the approximate
equalization of concentrations of various types of single-stranded redundant molecules.
The target differentially expressed molecules do not interact with driver, and therefore
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single-stranded tester becomes target enriched. Target molecules can still reassociate.
Again, reassociation is much more observed for high-abundance target molecules than
the low-abundance ones.
During the second stage, the two samples are mixed together without denaturing.
The remaining single-stranded molecules are therefore given another chance to
reassociate, forming double-stranded molecules. Redundant single-stranded molecules of
tester will primarily form hetero-hybrids with their driver complements, whereas the
single-stranded target molecules differentially expressed and enriched have no chance to
become double-stranded other than to anneal to their corresponding antisense strand from
the tester generating a new type e molecule. These new hybrids are double-stranded
tester molecules with two different ends, which correspond to the sequences of adaptors
2R and I. A freshly denatured driver cDNA is again added to further enrich fraction e for
differentially expressed sequences. After filling in the ends by DNA polymerase, the
type e molecules, the differentially expressed tester sequences have different annealing
sites for the nested primers on their 5’ and 3’ ends. The entire population of molecules is
then subjected to PCR to amplify the desired differentially expressed sequences. During
PCR, type a, and d molecules are missing primer-annealing sites, and thus cannot be
amplified. Due to the suppression PCR effect, most type b molecules form a pan-like
structure that prevents their exponential amplification. Type c molecules have only one
primer-annealing site and can only be amplified linearly. Only type e molecules, which
have two different adaptors, can be amplified exponentially. These are the equalized,
differentially expressed sequences.
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A secondary PCR amplification is performed using nested PCR primers to
further reduce any background PCR products and enrich for differentially sequences.
The subtracted cDNA was then inserted into a cloning vector. The subtractive
hybridization was performed using the Clontech PCR-Select subtraction Kit (Clontech
Laboratories Inc., Palo Alto, USA). In all technical details, the protocols described by
the manufacturer were followed. All PCR and hybridization steps were performed on a
Perkin Elmer 480 thermal cycler.
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Figure 3. Molecular basis of the PCR-Select cDNA subtraction
O'as
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Molecular basis of PCR-Select cDNA subtraction
IV.2 Construction of the subtracted cDNA library
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To construct the subtracted cDNA library, total RNAs were first extracted from
2C, 5.9 and other cell lines (B2DIII, 5.5, EL4, A20, Yac-1 and 3T3 cell lines), and then
fractionated by 1% formaldehyde agarose gel electrophoresis to check the integrity of
total RNAs. As shown in figure 4, two strong ribosomal RNA bands running 28 and 18 S
are observed, demonstrating that the RNAs are not degraded. Poly (A"^) RNAs were
purified from total RNAs extracted from 2C and 5.9 cell lines by two cycles of oligo
(dT)- cellulose chromatography (see material and methods). The first-and second strand
cDNA of the tester and driver were synthesized, and to confirm their efficiency, a test gel
was run, dried on a 3 MM Whatman paper sheet and then wrapped in a commercial wrap.
Autoradiography of the gel was performed by exposing on film (Kodak XAR-5 film)
overnight with intensifying screen. Figure 5 showing a pattern of smear between 0.5 and
12 kb in each lane demonstrates the synthesis of double strand cDNAs. The synthesized
tester and driver ds cDNAs were digested with RSA I restriction enzyme to yield short
and blunt-ended cDNA fragments. Uncut ds cDNA (tester, driver, and controls), and
Rsal digested ds cDNA (tester, driver, and controls) were run on a test gel. The gel was
dried on a 3 MM Whatman paper sheet, wrapped in Saran wrap and exposed on a film
overnight with intensifying screen to check the efficiency of Rsal restriction enzyme
digestion. Figure 6 shows that after the Rsal digestion, the average cDNA size is
decreased. At this stage, the preparation of the drivers’ cDNA was completed and stored
at -20 °C until needed, but the resulting tester cDNA fragments were subdivided into two
samples and each sample of tester cDNA was ligated at their 5’ end to different double
stranded adaptor I or 2R cDNA in two different tubes. To insure the success of ligation
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reactions, PCR reactions using primer1, specific to the two adaptors and 3’ or 5’
GAPDH specific primers were used to carry out the ligation efficient test. Figure 7
shows a pattern of smear seen on lanes 2 and 4 indicative of amplified fragments between
the two adaptors and 3’ or 5’ GAPDH primers, on lanes 3 and 5 a specific band of 0.5 kb
is seen corresponding the predicted fragment between 3’and 5’GAPDH primers. These
results demonstrate that the ligation reaction was successful. Sequential hybridization
reactions were therefore proceeded. An excess of driver cDNA was added to the tubes
containing each adaptor ligated tester cDNA to perform the first hybridization reaction.
The samples were then heat-denatured and allowed to anneal. For the second
hybridization, the two samples from the first hybridization were mixed together and a
freshly denatured driver cDNA was added to further enrich for differentially expressed
sequences. Prior to thermal cycling, the missing strands of the adaptors were filled in by
a brief preincubation at 75 °C to create the binding site for PCR primer 1. In the first
amplification, only double strand cDNAs with different adaptor sequences on each end
was exponentially amplified. In the second amplification, nested PCR is used to further
reduce the background and enrich for differentially expressed sequences. The secondary
PCR product was directly inserted in a T/A cloning vector, and the ligation reaction was
used to transform bacterial DH5a competent cells to obtain the subtracted cDNA library.
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Figure 5. Efficiency test of the synthesis of double strand
cDNA. First and second strand cDNAs of the tester, driver,
and controls were synthesized as described in material and
method. To confirm the efficiency of their synthesis, a




Figure 6. Analysis of RSAI digestion.
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becomes smaller.
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Figure 7. Ligation efficiency analysis.
Rsal tester digested cDNA fragments were subdivided into two samples and each
sample was ligated at its 5’end with different double strand adaptor cDNA. To
confirm the efficiency of the ligation reaction, PCR reactions were performed using
PCR primer 1, specific to the two adaptors and 3’ or 5’ GAPDH specific primers.
Lane M: ([iX molecular weight marker. Lane 1: negative control with specific
primers but without tester templates. Lane 2: tester-adaptor 1 cDNA amplified
using specific primer 1 and 3’GAPDH. Lane3: tester-adaptor 1 amplified using
3’and 5’GAPDH primers. Lane 4: tester-adaptor2R amplified using primerl and
5’GAPDH primer. Lane 5: tester-adaptor2R amplified using 3’and 5’GAPDH
primers.
Figure 8. Concepts behind the TA cloning method.
Taq polymerase has a nontemplate-dependent activity
which adds a single deoxyadenosine (A) to the 3’ends
Of PCR products. The linearized pCR II vector has
single 3’ deoxythymidine (T) residues. This allows
PCR inserts to ligate efficiently with the vector.
IV. 3 Isolation and characterization of di^erentially expressed cDNA clones
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To isolate and characterize differentially expressed cDNA clones, colonies were
randomly picked from the subtracted library, and each bacterial colony was grown
overnight in LB-amp in a 96 well plate. Amplification of each insert was performed
directly on bacterial colonies, using nested PCR primer I and 2R. Figure 9 shows the
resulting PCR products when resolved on a 2% agarose gel electrophoresis. All the PCR
products were run on three different agarose gels. On gel I, (|)X molecular weight marker
is on lane 1, the PCR negative control without template is on lane 2 and on the remaining
lanes are the amplified inserts. On gels n and HI, the molecular weight marker is also
loaded on lane 1 and the amplified cDNA inserts can be seen on the remaining lanes. To
screen the differentially expressed cDNAs, the resulting PCR products were first
denatured and arrayed in duplicate on nylon membrane. Two identical blots were made.
To use as probes for differentially screening, excess of adaptors was removed from the
forward and reverse subtracted cDNAs by restriction enzyme digestion. The resulting
digested forward and reverse subtracted cDNA products were ^^P-radiolabelled and
hybridized with each cDNA arrayed on membrane. Positive hybridizations were
observed with the forward subtracted cDNA probes as indicate arrows on figure 10, but




Figure 9. Amplification of differentially expressed cDNAs by PCR.
Bacterial colonies were randomly picked from the subtractive
library plate and grown at 37 °C overnight in 2 x YT-amp medium
in a standard 96 well culture plate. Insert was amplified using each
bacterial colony as template source, and nested PCR primers 1 and 2R.
The amplified PCR products were run on 1% agarose gel.
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Figure 10. Dot-blot screening of differentially expressed cDNA clones.
Amplification enriched PCR product from each clone was denatured and dot-blotted on nylon
membrane. The array was hybridized to labeled subtracted cDNA after removal of the flanking
adaptor sequences by Rsal digestion. Positive clones are arrowed. Numbers on the rows and
letters on the columns represent the 96 well plate equivalent replica on the filter membrane.
DNA was spotted in duplicate.
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To confirm the results of the differentially screened cDNAs, virtual northern
hybridization experiment was carried out by blotting side by side the forward-and
reverse-subtracted cDNAs on nylon membrane. Probes were prepared first by growing
for plasmids purification, each bacterial clone harboring differentially hybridizing cDNA
sequence. Differentially expressed cDNA insert, isolated by PCR using nested PCR
primers 1 and 2R was P^^-labeled and hybridized with the virtual northern blot. As
observed on Figure 11, all isolated and radiolabed differentially expressed cDNA inserts
hybridized with the forward subtracted cDNA on the virtual northern. No hybridization
was detected with the reverse subtracted eDNA. This result suggests that the differential
screening experiment was very successful. All differentially expressed cDNA clones in
addition to some clones randomly picked in the library were sequenced and database
search was performed using the blast x program of the National Center for Biotechnology
Information (NCBI). Table II shows the result of the data base search. The partial
sequences of 3F and IB cDNA clones are presented in figure 12. Database search of
these two cDNA clones as indicated in figure 13 shows very limited identity to known
proteins.
To determine cDNAs specifically expressed, northern hybridization was carried
out using each cDNA as radiolabeled probe on total RNA extracted from various types of
cell lines. The result of the northern blot revealed that 7 cDNA clones were expressed on
all the cell lines except cDNA clones 1, 3F, IB and 6D that are expressed only on 2C and
A20 cell lines. Figure 14 shows the expression of 3F and IB cDNA on total RNA of
various types of cell lines. Ethidium bromide staining of the RNA gel is shown on the
lower panel to demonstrate the equal amount of total RNA loaded. A complete
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correlation was found between the expression of these two clones and the transcription
from mouse genome. This finding was accomplished by southern blot analysis in which
genomic DNA isolated from mouse spleen tissue was digested with PstI, EcoRI, or Rsal,
the digests were electrophoresed in duplicate set and blotted on nylon membrane. Each
set of enzymatic digest blot was hybridized with 3F or IB cDNA probe. In figure 15,
each probe displayed a different detection pattern of hybridization, suggesting that each
probe is transcribed from a different gene in the mouse genome, although the possibility
that the two cDNA clones could be derived from the same transcriptional unit via
alternative splicing could not be ruled out.
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Figure 11. Representative confirmation result of the differentially expressed cDNA
clones by virtual northern blot analysis. A series of forward and reverse-subtracted
cDNA pairs were electrophoresed on agarose gel and transferred onto nylon membrane
filters. Cut filter strips containing forward and reverse-subtracted libraries were
hybridized to selected labeled purified inserts derived from each positive clone identified
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Figure 12. Nucleotide sequences of 3F and IB cDNA clones. PCR products were
cloned into pCR® 2.1 vectors and sequenced with SP6 or T7 primers using either Dye or
BigDye Terminator Cycle Sequencing Ready Reaction Kit and ABI 377 automated DNA
sequencer (ABI prism) according to the manufacturer recommendations. The underlined




MTF1_M0USE TRANSCRIPTION mCTOR MTF-1 (MRE-BINDING TRANSCRIPTION FACTOR
and {Pasted_No.1.22:189-88)
Length * 675
Score = 27.8, bits (60.0), Exjpect = 0.66
Identities = 15/34 (44%), Positives =2Q/34i (59%)
Query: 189 LLTXTSESHLFLALSRGPGA*PPIFGPCPSIIQP 88
LL T+ S A S GPG+ P FG P+++QP
Sbict: 4a3 LLPATAPSAPPPAPSLGPGSQPAAFGSPPALLQP 466
B/
Alignm.ent between:
EGRl_MOUBE EARLY GROWTH RESPONSE PROTEIN 1 (EGR-l) (KROX-24 PROTEIN) (Z
and {Pasted_No.1.14:177-73)
• Length = 533
Score = 28.2, bits (61.0), Expect = 0.25
Identities = T5/37 (41%), 'Positives = 21/37, (57%)
Query: 177 ’^PPQFPQMTEKFPKP—ySN*PTSSLLASVTALFAPQ 73
VPP FP FP S+ TS+ LH- +TA F+P+
Sbjct: 492 VPPAFPTQVSSFPSAGVSSSFSTSTGLSDMTATFSPR 528
Figure 13. Amino acid sequence alignment of A/ 3F and mouse transcription factor MTF-1, B/ IB
and mouse early growth response protein-1 (EGR-l). Identical and conserved (+) amino acid are
indicated between the query and the subject. The alignment was made by using the BLAST X
program (NCBI).
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Figure 14. Northern blot analysis of 3F and 1 B mRNA expressions in
various cell types. 2C, B2DIII, 5.9, 5.5, EL4, A20, Yac-1, and NIH-3T3 cell
lines were grown as previously described. Total RNA was isolated from each
cell line, electrophoresed on a formaldehyde denaturing gel, blotted, and
hybridized with 3F and IB cDNA probes. Each lane contains 10 |ig of total
RNA as measured by absorbance at 260 nm. Ethidium bromide stained of the
RNA gel is shown on the lower panel.
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Figure 15. Southern blot analysis of genomic DNA. High
molecular weigh DNA isolated from mouse spleen tissue
after overnight digestion with EcoRI, PstI, or Rsal was
fractionated by agarose gel electrophoresis, transferred to
nylon membrane, and probed with 3F and IB cDNA clones.
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IV.4 Expression of IB and 3F cDNA clones on CD8^ and CD4^ cytotoxic T cells
puriHed from primary MLRs.
CDS and CD4 cytotoxic T cells were purified from primary MLRs by negative
selection using the stempSep separation method (see material and method section). The
separated cells were labeled and then analyzed by flow cytometry and respectively 93%
and 94.5% of pure CD4 and CDS CTLs were obtained as indicates figure 16. Total RNA
was immediately extracted from each purified cell, followed by reverse transcription of
the RNA using oligo (dT) or random primers. Each reverse transcribed reaction was
quantitated by a set of ribosomal 1S S genes specific primers. The expression of 3F and 1
B cDNA clones were analyzed hy RT-PCR using a set of gene specific primers, and the
same amount of each reverse transcription reaction used during the quantitation by the
ribosomal 18 S primers. In figure 17, the 18 S primers show the integrity of the RNA and
also the quantitation of the RT-PCR reaction. 3F and IB cDNA clones are both
expressed in CD8 cells derived sample RNA but not in CD4. This result suggests that 3F
and IB are cDNAs constitutively expressed genes in cells.
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Figure 16. Flowcytometry analysis of cells purified from primary MLRs.
A/ Purified CD4'^T cells stained with anti-mouse CD4.
B/ Purified CD8-h T cells stained with R-PE anti-mouse CD8a. The labeled cells
were analyzed by flowcytometry and respectively 93 % and 94.5 % pure CD4'^








Figure 17. Analysis of the expression by RT-PCR of the 3F and IB
cDNA clones in cells purified from primary MLRs. PCR with a set of
18s rRNA primer was used to insiu-e the RNA integrity.
IV.5 Initial cloning of IB and 3F cDNAs
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The 300 base-pair (bp) IB and 3F cDNA fragments isolated through SSH were
used as probes to screen a Xbal- (dT)i5 [an oligo (dT) primer including an Xbal
restriction site]-primed mouse spleen 5’-STRETCH cDNA library XTriplEx (Clontech
Laboratories, Inc., Palo Alto, CA). After three rounds of plaque purification, nineteen
and thirteen positive individual phages were respectively isolated for 3F and 1 B cDNA
clones as described in material and method. Each individual phage was converted to
pTriplEx plasmid as described in material and method and the purified plasmids were run
on agarose gel for the selection of plasmid with longer insert (figure 18A & B). To
determine the size of each insert, all the selected purified plasmids were digested with
EcoRI/Xbal restriction enzymes and the resulting restriction enzyme digestion products
were electrophoresed on agarose gel (figure 19A & B). Only 1,554 bp of clone 14-lB
were sequenced as shown by figure 20. The IB cDNA fragment used as probe for the
screening has not been detected yet. Database search still using the BLAST X program
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Figurel9-A. Size determination of insert by restriction enzyme digestion.
The purified pTrriplEX plasmid (14-lB) was EcoRI/Xbal digested and run in duplicate on a
1% agarose gel. The non digested plasmid, also run in duplicate was used as control. As the
photograph shows, 14-lB is ~2, 3(X)bp in size. M represent X Hindlll molecular weight marker.
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Figure 19-B. Size determination of insert by restriction enzyme digestion.
The selected pTriplEX plasmids were EcoRI/Xbal digested and run on agarose
gel electrophoresis. As the photograph indicates, clone has an insert of
~l,100bp. Ml and M2 respectively represent X. Hindlll and lOObp ladder
molecular weight markers.
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5’ GAA TTC GCG GCC GCG TGC ACC GCG CCC GGT CTC CTC CCC GCG AGC GCG GAG CGG
CGA GCC CGG CGC GGC CAT GGG GAG TGG GAT GAG CCA GAC CCT GCC GGG CCT GTA
CAT TGG CAA CTT CAA AGA CGC AAG AGA TGC AGA ACA GTT GAG CAG GAA CAA GGT
GAC ACA CAT TCT TTC TGT GCA CGA TAC TGC CAG GCC CAT GTT GGA AGG GAG TTA
AAT ACC TGT GTA TTC CAG CGG CAG ACA CAC CAT CTC AAA ACC TGA CAA GAC ATT
TCA AAG AAA GCA TTA ATT CAT TCA TGA GTG CCG ACT CCA TGG TAG AGC TGT CTT GTA
CAT TGC CTG GTG GGG TCT CCA GGA GTG TGA CAT TGG TGA TCG CAT ACA TCA TGA
CTG TCA CCG ACT TTG GCT GGG AAG ATG CCT TGC ACC ACT GTT CGT GCG GGG AGG
TCC TGT GCC AAC CCC AAC CTG GGC TTT CAA AGG CAG CTG CAG GAG TTT GAG AAA
CAT GAA GTG CAC CAG TAT CGG CAA TGG CTG AGA GAA GAG TAT GGA GAG AAC CCT
TTG CGG GAT GCA GAA GAA GCC AAA AAT TAT TCT GGG TAA ATA TAA AGA GCA AGG
GCG CAT GGG AGC CCC GGC CTG GCA GCA GGC GGT GGA GCA GCT TGT GAC CCT GCC
TCC TCT CAC CTA CAA TAA CTA CAC AAC AGA GAC CTA ACA GAG AGA GCT GGT GTC
TGC CTT CCT GCT GCG GGT CTT CTG GGT TGC CTA CCA TGT GCT GGT GTG CCT GGT GTC
CTG GCT CCT GCC TCG CAG GAC TAC GAG AGG AGG TCG CAG CAA GGT GGA GCA CTC
AGG GCT CCT TCT CAG AAT ACC GCC CTA CTC AGG CTT TTC ACT CTC CCA TCT TCG CCC
CAT CTT TTC CTC ACC TGA ACT TGC CCA GCC TGG GAT GCT GCC CGG CCA CCG TGT ACT
TCT CGT ATG CGT GCA GGC GTG TGG ATG TGC ATG TAT GTG TCT AAG AGT GTG CAT ATA
TAC CTA CAA ATG TAT GCA TTG TGA ACA AGT ACA CAT GTA AAT GTG TCT CTG CAT GTG
GGC ACT GAG TGT TTA TGG TGC TGA AAG TTA TAA ACA TCC GCT GCC AGA ACT GCA
ATG GTC ACA TTG TTC AGT CCA CAT GGA AGT CAT TGA ACT TGG CCT CTG GAA AGC TAC
TCA CCA AGT AAC AGC TTA TGC CTG TGC TGA GTG AGA GCT CAG GGT GTG GGC AGC
TGG AAA CAG TGG TGT TCC AGA TTC TGA GAT GGC ACA GAG GAA GGG ACA GGA CCC
TCC TGA GGA AGA GTG GCA TAA TCC TAG AGA GTT TTA TGT CTG TGG GAA CAA GGG
AGG GGC TTT CTG AGC ACT GTC TTG GAC TTG ATA AGT ATA CTT GCC AGC CCG TCA TGG
CCC TGA GTT CCA CTG GTG CCT GCT CTG CGT GGG ACC AGC GTC ATT TGA CTT TCA TGG
TGA TAT GGT ATG GTG ACA GGG TGG ACC TGA GAC TCA GTA GCC CTA TAC CAG AGG
TCT GGC CCA CCT CTG TCT GCT TTT AAA CAC TTT AGC CTC TGG CTT AGC CTC TTG TTG
CAG GGG TCT CAT-3’
Figure 20. Nucleotide sequence of 14-IB clone.
The selected clone 14-IB of -2,300 bp of obtained after the X TriplEx cDNA library
screening using probe IB fragment. Only 1,554 bp was sequenced.
CHAPTER V
DISCUSSION
The major aim of this research was to isolate cDNA clones encoding proteins that
may be involved in the passive resistance of cytotoxic T cells to granule-mediated lysis.
As a source of the isolated cDNAs, the 2C cell line (a CDS T cell) was used in
subtractive hybridizations against an inflammatory CD4 T cell line, the 5.9 cell line.
These two cell lines are known to be resistant to granule-mediated lysis, but after
treatment with ATP depleting reagents (azide, cyanide, 2-deoxyglucose) and the 2C cell
line remained strikingly resistant to granule-mediated lysis, while the 5.9 cell line became
susceptible. Based on this observation, it was found that cell could be resistant to lysis
either by ATP-dependent (active resistance) or ATP-independent (passive resistance)
manner. The ATP-dependent mechanism may reflect the clearing of cell membranes of
inserted perforin, like the mechanism used by many nucleated cells to reduce their
susceptibility to lysis by activated complement, possibly via endocytosis of affected
plasma membrane (63). This attribute could be generalized to all murine CD8-I- clones.
Verret et al. found that the active resistance mechanism appears to be well developed in
€04"^ T cells (both cytolytic and noncytolytic). The mechanism responsible for the ATP-
independent (passive) resistance of CDS"^ CTLs is still unknown.
A subtractive cDNA library was constructed to identify cDNAs encoding proteins
differentially expressed by cytotoxic T cells. Numerous cDNA subtraction methods have
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been reported. In general, they involve hybridization of cDNA from one population
(tester) to excess of mRNA or cDNA from other population (driver) and then separation
of the unhybridized target fraction from the hybridized common sequences. Usually
hydoxylapatite chromatography 68, avidin-biotin binding (69, 70, 71), or
oligo (dT)3o-latex beads are used for the separation step (72). These methods had been
successfully used for the isolation of important genes such as the T-cell receptor, but they
are usually inefficient for obtaining low abundance transcripts. These techniques also
require at least 20 |ig of poly(A'^) RNA, involve multiple or repeated subtraction steps,
and are labor intensive.
A recently PCR-based technique, the representational difference analysis (RDA),
has been successfully used to enrich genomic fragments that differ in size or
representation (73) and to clone differentially expressed cDNAs (74), but still does not
resolve the problem of the wide differences in abundance of individual mRNA species.
As a consequence, multiple rounds of subtraction are still needed (74). The mRNA
differentially display (75) and RNA fingerprinting by arbitrary primed PCR (76) are
faster methods to identify differentially expressed genes. However, both techniques have
high level of false positives. Recently, protocols using cDNA microarrays with
fluorescent labeled probes have been introduced (73, 77). The chip technology is highly
efficient, but requires expensive equipment for making the microarrays and for detecting
the fluorescence signals. Thus, chips technology is not widely available.
During this study, a new PCR-based cDNA subtraction method, termed
suppression subtractive hybridization (SSH) was used. SSH selectively amplifies target
cDNA fragments (differentially expressed) and simultaneously suppresses nontarget
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DNA amplification. This method is based on the suppression PCR effect: suppression
occurs when complementary sequences are present on each end of a single strand cDNA.
During each primer-annealing step, the hybridization kinetics strongly favor (over
annealing of the shorter primers) the formation of a pan-like secondary structure that
prevents primer annealing. When occasionally a primer anneals and is extended, the
newly synthesized strand will also have the inverted terminal repeats and form another
pan-like structure (77). The subtraction described here overcomes the problem of
differences in mRNA abundance by incorporating a hybridization step that normalizes
(equalizes) sequence abundance during the course of subtraction by standard
hybridization kinetics. The SSH eliminates any intermediate steps for physical separation
of ss and ds cDNAs, and requires only one subtractive hybridization round. During the
first hybridization, the excess of driver cDNA would have eliminated most of the
common sequences between the tester and driver cDNA samples. However,
quantitatively different cDNA species may still remain in the tester populations. To
further eliminate common sequences, another excess of denatured driver cDNA was
added to the samples in the second hybridization step, thereby further subtracting
quantitatively different but common sequences between the tester and driver populations.
Digestion of the cDNAs with Rsa I restriction generated the largest average size
of ~ 600 bp fragments. Although this may be a disadvantage when full length cDNAs are
desired, dividing each cDNA into small fragments has two important advantages. First,
long DNA fragments may form complex networks that prevent the formation of
appropriate hybrids. Second, cutting the cDNAs into small fragments provides better
representation of individual genes. Derived from related but distinct members of the
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gene families, cDNAs often have similar coding sequences that may cross-hybridize
and be eliminated during the subtraction procedure (78). Further, different fragments
from the same cDNA may vary considerably in terms of hybridization and amplification
characteristics and may not hybridize or be amplified (79, 80). Thus, some fragments
from differentially expressed cDNAs may be eliminated during the SSH procedure.
However, other fragment from the same cDNA may be enriched and isolated. Once a
small cDNA fragment is cloned and sequenced, numerous approaches, including several
PCR based methods, can be used to quickly obtain corresponding full-length cDNAs
(77).
The high level of enrichment, low background, and normalized abundance of
cDNAs in the subtracted mixture make the SSH the method ideal for rapid cloning of
cDNAs of differentially expressed genes. The feasibility of using the uncloned
subtracted cDNA mixture as a hybridization probe makes this technique versatile and
powerful.
The subtracted cDNA pool was analyzed after cloning in the pCR II cloning
vector. Bacterial colonies randomly picked (106) from the library were directly
amplified with nested PCR primer 1 and 2R. The PCR analysis revealed inserts in the
range of 200-700 bp. Initially 96 cDNA clones were selected and tested for selectivity by
reverse northern dot-blot hybridization with ^^P-labelled tester or driver cDNA. Only 13
differentially expressed cDNA clones were observed with the labeled cDNA tester and no
hybridization was observed with the labeled driver (data not shown). To ensure
exclusion of false positive clones, the dot-blot analysis was confirmed by hybridizing a
blot of forward (F) and reverse (R) subtracted cDNAs run side by side with each selected
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^^P-labeled differentially expressed cDNA. These differentially expressed cDNA
clones in addition to 10 randomly picked from the library were sequenced. Pair-wise
comparison using the blast sequence 2 programs revealed that 7 cDNAs are unique and
clone 7 is identical to 8H, 1 B is identical to 1, and 3 F is identical to 6D. Of the 23
sequences, only 6 were redundant, suggesting that the subtracted cDNAs are normalized
and highly complex. Northern analysis of the selected cDNA clones with total RNA
extracted from 2C, 5.9 and others cell lines reduced the number of differentially
expressed cDNA clones to two, the IB and 3F cDNA clones expressed only in 2C but not
in 5.9 cell lines. Cloned 2C and 5.9 cell lines, maintained in culture for several years
with the support of high levels of IL-2, and repeated exposure to granules when
periodically stimulated with targets may have induced the synthesis of proteins. The
expression of IB and 3F cDNA clones in purified cells from primary mixed lymphocytes
reactions (MLRs) that had been in culture for only 5 days shows that these two cDNAs
are expressed in CDS"^ CTL but no expression was observed in CD4'^ T cell. This result
suggests that IB and 3F are constitutively expressed cDNAs. Data base search of all
selected cDNAs using the blast X sequence program gives the results presented in table
n. BLAST X program was used for its ability to translate nucleotide sequences in all six
reading frames and also to find short stretches of similarity to known proteins. None of
the cDNAs sequenced were similar to known cytotoxic T cells’ proteins such as perforin,
CDS"^ T cell, CD4'^ T cell, or T cell receptor genes. Failure to identify these proteins may
be due to the statistical limitations of picking only 106 clones from the constructed
library, or these cDNAs may have been removed during the hybridization steps due to the
similarities in their coding regions. Overall, the significance of the similarities presented
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in table II exhibited limited proteins similarities with the BLAST X sequence analysis
program, therefore these cDNAs can be considered as unknown and will require further
sequence information, such as cloning of the full length to confirm their relationships to
other genes. The results presented here show that IB and 3F cDNA clones are expressed
only in 2C, but not in 5.9 cell line and also for physiological relevance, these two cDNAs
are expressed in CDS"^ T cell purified from primary MLRs, suggesting that they are not
induced cDNAs due to the CTLs’ culture conditions. Thus these two mRNAs are good
candidates for functional evaluations that might demonstrate whether or not they specify
protective proteins.
The first approach toward gaining clues regarding function was to obtain
sequence information. Sequence data on IB and 3 F reveals respectively limited
identities to early growth response protein 1 (EGR-1) (KROX-24 protein) (ZIF 268)
(41% / 37 aa) and transcription factor MTF-1 (MRE-binding transcription factor) (44% /
34 aa). Metallothionein transcription factor-1 (MTF-1) is a member of the Cys2His2
family of zinc finger transcription factors (81) that depends on the activation of both
constitutive and stress-inducible expression of metallothioneins (MTs). MTs have well-
established roles in metal homeostasis and in the detoxification of heavy metals.
Moreover, they also confer protection against reactive oxygen intermediates, electrophilic
anti-neoplastic agents, various mutagens, ionizing radiation, and nitric oxide (82, 83).
Other studies indicate roles for the MTs in regulation of cellular proliferation and
apoptosis (84-87), perhaps through an interaction of MTs with nuclear-kB-DNA
complexes (88). MTF-1 may be also important for tumorigenesis not only through MT
expression but also through its regulation of other genes. For example, MTF-1 activity is
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necessary for the expression of y-glutamylcysteine synthetase (89), the rate-limiting
enzyme for the synthesis glutathione (GSH) (90). GSH is a major contributor to cellular
defenses against environmental alkylating agents and oxidants, including reactive oxygen
species generated by ionizing radiation (90). Thus, MTF-1 may be critical for
modulating gene expression associated with malignant phenotypes such as resistance
therapy.
The early growth response protein-1 (EGR-1), referred to as NGFI-A (91), Krox-
24 (92) and zif/268 (93) is an immediate early gene, with zinc-finger DNA-binding
properties that acts as a nuclear coupler of early cytoplasmic events to long-term
alterations in gene expression (94). The Egr-1 protein binds to a specific GC-rich
sequence in the promoter region of many target genes to regulate their expression (95,
96). It was found that Egr-1 has been functionally implicated in cell proliferation,
differentiation and apoptosis during the differentiation of rat calvarial preosteoblasts (97).
Even in some cells, Egr-1 not only acts as a transcriptional activator, but also as a
repressor (98, 99) and has been shown to negatively regulate tumor growth in human
fibrosarcoma cells (100). The relationship of IB and 3F respectively to Egr-1 (41% / 37
aa) and MTF-1 (44% / 34 aa) is very limited in term of similarity, but the information
provided above might be important clues related to their functions. Presently, we are
searching for the full length of these two differentially expressed cDNA clones by
screening premade cDNA libraries using IB and 3F as radiolabeled probes.
Convincing functional demonstration may be difficult, even if IB and 3F are in
fact truly protection gene products. This may be so, as many phenomenon are occurring
in resistant cells (regulation of gene expression, clearing of cell membrane, active ion
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pumps that prevent or restore the marked changes in intracellular ion concentrations),
any one of which may lead to cell resistance. However, one or both of these mRNAs
might specify proteins that are essential in protecting cell, as is apparently the case of the
products ced-9 gene, similar to mammalian Bcl-2, which acts to prevent apoptosis in
mammals (101). In this regard, the MTF-1 and EGR-1 proteins encoded respectively by
3F and IB cDNA clones might function as essential regulatory components. If this so,
use of complementary oligonucleotides might favor programmed cell death. Such
oligonucleotides are readily taken up by mammalian cells in culture, leading to
hybridization-based blockage of translation or degradation of specific mRNAs.
Transfection of full-length cDNA clones is another option that might lead to functional
testing via regulated expression in other types of cells.
The chances of identifying a gene product that is essential in resistance of cells
would be increased if more cDNA clones can be picked from the library. Our subtracted
cDNA library contains many clones that did not hybridize with the subtracted cDNA
probe in the differential screening. Some of these clones represent low-abundance
mRNAs that might function specifically in the resistance of cells. Therefore, the library
will be screened again using more sensitive detection procedures.
The SSH coupled with the PCR-Select differential screening procedure used to
isolate IB, 3F, and several other clones has several desirable features that contribute to its
efficiency and reproducibility. The procedure requires only 0.5-2 |ig of poly A"^ RNA
and does not requires physical separation of ss and ds molecules (SSH manual, page 4).
Furthermore, suppression PCR prevents undesirable amplification while enrichment of
target molecules proceeds. Another useful feature is the PCR amplification step.
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Because oligo (dT) primer-adaptor was used to prime synthesis, only cDNA inserts
were amplified, thus increasing the purity of molecules to be used in construction of the
enriched library. The amplification from this step also improves the chances of cloning
sequences representing rare copy mRNAs, particularly in cases where transformation
efficiency is low. Finally, inserting the secondary PCR products into pCRII using the
T/A cloning kit (INVITROGEN), as opposed to directional insertion is a helpful feature in
that it allows the cloning of cDNA fragments without internal enzyme-digestion.
In this study, the SSH coupled with PCR-Select differential screening was
employed to enrich for cDNA clones that may be involved in the passive resistance of
cells to granule-mediated lysis. From the one hundred six colonies randomly picked,
only 13 clones were differentially expressed. Sequencing and northern analysis of the 13
clones reduced the number of differentially expressed genes to two, the IB and 3F cDNA
clones, that have no similarities to known proteins. These two cDNAs are probably
involved in the passive resistance because they are isolated from a library constructed
with mRNA from 2C cell and 5.9 cell lines. Further experiments such as cloning of the
full-length and functional characterization of these two mRNAs need to be done to know
their exact functions in T cells.
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